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The placenta is an active immunologic organ, modulating the maternal environment to support 
the conceptus. Fetal trophoblasts produce a variety of products including pregnancy-associated 
glycoproteins (PAGs) and extracellular vesicles called exosomes. PAGs directly interact with the uterus 
and maternal immune cells with low concentrations correlating with adverse pregnancy outcomes in 
cattle. Exosomes contain nucleic acids and proteins that influence intercellular communication during 
pregnancy. The specific objectives of this body of work were to 1) quantify circulating PAG 
concentrations, 2) characterize the profiles of circulating exosomal proteins and miRNAs in pregnant and 
non-pregnant sheep, and 2) determine the difference in exosomal content profiles between non-infected 
and BVDV-infected pregnant and non-pregnant sheep. Twenty-four yearling ewes, found to be negative 
to BVDV on serum neutralizing antibody serology, were enrolled in this study. Ewes were inoculated 
with BVDV NY-1 or sham media. Fifteen days post inoculation, all animals underwent hysterectomy and 
peripheral blood collection. PAG1 concentrations were quantified using commercially available ELISA. 
Exosomes were isolated using ultracentrifugation and gradient density separation.  Small RNA high 
through-put sequencing and mass spectroscopy proteomics were performed. BVDV infection status was 
determined with BVDV PCR of fetal tissue, IHC of placentomes, and VN of dams. Statistical differences 
between circulating concentrations of PAG1, miRNAs, and proteins were analyzed by analysis of 
variance for repeated measures. PAG1 concentrations in maternal blood differed between treatment 
groups, with mean concentrations significantly lower (P =0.04) in BVDV inoculated dams compared to 
controls. Sixty million reads, identifying 1634 miRNAs were identified following high-throughput 
sequencing. Several miRNAs were identified to be unique to BVDV exposure and pregnancy status.  
With a confidence rate of 0.01, 539 proteins were identified with differential relative abundance between 
viral exposure. In conclusion, infection with BVDV decreases PAG1 concentration in maternal 
circulation in pregnant sheep compared to healthy controls. Exosomes containing select miRNAs and 
proteins are present in peripheral circulation likely have a biological role in fetal-maternal interactions 
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important in times of both disease and health. Maternal PAG concentrations and differential exosome 
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The placenta is essential for development of the fetus and maintenance of pregnancy. Cellular 
communications between maternal and fetal tissues are critical to create an intrauterine environment 
acclimated for fetal survival. Successful pregnancy requires modulation of the maternal immune system 
by placental and endometrial production, among many other needs. Dysfunction of maternal-fetal 
communication can contribute to detrimental effects and mortality of the fetus during times of 
reproductive pathology induced by pathogens. In this review, an overview of placental physiology and 
immunity during health and disease conditions will be presented.  Biogenesis and function of exosomes 
and corresponding miRNA and protein content and their significance associated with pathologic 
pregnancies is summarized.  
1. Placenta form and function in sheep  
The placenta is a transient, yet critical organ responsible for maintenance of pregnancy and 
preparation for lactation following parturition.  Additionally, the placenta supports the developing fetus 
by allowing nutrient exchange and immunologic protection.  Both fetal and maternal components make 
up the formed placenta. Description of the placenta is based on two criteria: 1) histologic separation 
between maternal and fetal blood and 2) anatomical distribution of villus attachment. The ruminant 
placenta is classified as synepitheiochorial with cotyledonary attachment that develops during 
embryogenesis (Spencer & Bazer, 2002). Following fertilization, the sheep embryo enters the uterus by 
day 3 of gestation and through mitotic development of the zygote a blastocyst forms, which is comprised 
of cells required for extraembryonic membrane formation (Bazer, 2012; Sherer & Abulafia, 2001). Prior 
to implantation, the extraembryonic membranes consist of the yolk sac, chorion, amnion, and allantois 
(Clemente et al., 2009; Senger, 2004). The yolk sac derived from the primitive endoderm, is transient and 
regresses with conceptus development, yet its lasting contribution are the germ cells lining the genital 
ridge in the embryo (Senger, 2004). The trophectoderm, comprised of mononuclear trophoblast cells, 
along with the mesoderm give rise to the chorion. Combination of the trophoblasts and endoderm forms 
the fluid filled amnion immediately surrounding the developing fetus. The allantois, an invagination of 
the primitive gut, forms to collect liquid waste originating from the embryo. Eventually the chorion and 
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allantois will fuse, forming the fetal portion of the attaching placenta (Senger, 2004).  Interdigitation of 
the fetal chorionic cotyledon with the maternal caruncular regions begins at 16 days following 
fertilization with attachment of the embryo occurring around 18 days (Stewart et al., 1992). The 
trophoblast of the developing conceptus produces interferon-tau (IFNT), which serves as the signal for 
maternal recognition of pregnancy (Reynolds et al., 2015; Spencer & Bazer, 2002). INFT achieves this 
function by inhibiting endometrial oxytocin receptors which in-turn inhibits estrogen receptors and 
prostaglandin F2-alpha (PGF2α) synthesis (Martal et al., 1997; Spencer & Bazer, 2002). Without the 
luteolytic activity of PGF2α, the ovarian corpus luteum continues to produce progesterone, the hormone 
required for maintenance of pregnancy.  
Epitheliochorial placenta, the least intimate of placenta types, has three intact maternal tissue 
layers and three fetal layers, 6 in total separating maternal and fetal blood.  However, ruminants’ 
epitheliochorial placenta erodes into the maternal endometrium allowing access to maternal circulation by 
the invading fetal chorion (R. M. Wallace, Pohler, Smith, & Green, 2015). This placental feature of 
endometrial erosion defines the synepitheiochorial placenta type found in ruminants. Two trophoblast 
populations histologically comprise the developing synepitheiochorial ruminant placenta: binucleated 
giant and mononuclear trophoblasts.  Giant binucleated cells arise from mononuclear trophoblasts at 2 
weeks of gestation in sheep (Grazul-Bilska et al., 2011). The binucleated trophoblast migrate through the 
chorionic microvillar junction eventually fusing with maternal uterine epithelium forming multinucleated 
fetal-maternal syncytial cells (R. M. Wallace et al., 2015). In cattle, these syncytia are transient and 
disappear by day 40 of pregnancy. Yet in small ruminants (sheep and goats), these syncytia persist 
throughout gestation (R. M. Wallace et al., 2015). Villous chorionic cotyledons interdigitate with 
aglandular maternal uterine caruncles creating regions of fetal-maternal interaction in the form of 
placentomes (R. M. Wallace et al., 2015). Direct engagement with maternal tissues is unique to the 
ruminant placenta compared to other epitheliochorial placenta. By gestational day 30, placental 
attachment is well established (Senger, 2004).  In ewes, the placentomes form a concave structure that 
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will increase in surface area throughout fetal development thus increasing nutrient exchange to keep up 
with fetal growth demands.  
Cotyledons are discrete button-like structures that contain abundant amounts of blood supply. As 
mentioned above, the surface are of these structure increase through pregnancy, increasing the possibility 
for maternal-fetal interactions.  The endocrine activity of the placenta increases with fetal development as 
well and placentally produced hormones gain access to both maternal and fetal compartments (Reynolds 
et al., 2015). The gestation length in the ewe is approximately 150 days; binucleate trophoblasts begin 
producing progesterone following 2 weeks of gestation. By gestational day 50-75 in sheep, the placenta 
overtakes the ovarian corpus luteum, making the majority of progesterone needed to maintain pregnancy 
until parturition (Reynolds et al., 2015; Wathes et al., 1996). After this time, luteolytic agents (i.e. 
PGF2α), whether endogenous or exogenously derived, are unlikely to induce abortion alone. The high 
concentration of placentally produced progesterone also blocks myometrium contractility preventing fetal 
expulsion (Spencer & Bazer, 1995). Furthermore, high progesterone concentration aids in increased blood 
supply to the uterus needed for the developing (Spencer & Bazer, 2002). Binucleated trophoblast also 
create many other products including pregnancy-associated glycoproteins (PAGs), placental lactogens, 
and prelatic-related proteins. These trophoblast-expressed proteins are delivered to the maternal uterine 
connective tissue through secretory granules. All of these products can reach maternal blood circulation 
as verified by positive measurements in maternal blood (R. M. Wallace et al., 2015).  The exchange of 
these proteins does not necessarily go both ways. In epitheliochorial, endometrium proteins and lipids do 
not cross the placental barrier into the fetal compartment (Bairagi et al., 2016).  Instead, the maternal 
tissues utilize other forms of cross talk with the fetal placenta in the forms of extracellular vesicles 
(described below).  
2. Pregnancy Associated Glycoproteins (PAGs) 
PAGs are placental products abundantly expressed by even-toed ungulates, such as ruminants 
(Telugu, Walker, & Green, 2009). PAGs are subdivided into ‘ancient’ or ‘modern’ groups based on 
phylogenetic origination (Hughes, Green, Garbayo, & Roberts, 2000). Individual PAGs are further named 
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numerically based on series of which they were sequenced or location on gene loci (R. M. Wallace et al., 
2015).  Cattle and sheep, belonging to the suborder Ruminantia produce a larger concentration of 
‘modern’ PAGs compared to ‘ancient’ PAGs. Two dozen PAG genes, encoding for corresponding 
proteins, have been identified in the bovine and ovine genome (Telugu et al., 2009). PAGs can be 
expressed in both mononuclear and giant binucleated trophoblast (R. M. Wallace et al., 2015). PAG 
antibodies are identified via western blot in day 16 bovine conceptus, prior to binucleated trophoblast 
formation. Immunolocalization studies have identified that modern PAGs are more abundant in 
cotyledons compared to the intercotyledonary chorion.  Conversely, ancient PAG transcripts are elevated 
at intercotyledonary areas (R. M. Wallace et al., 2015). Numerically annotated, individual PAGs are 
produced by different trophoblasts; for example, PAG-1 is produced by binucleate trophoblasts, while 
PAG-2 is produced by both bi- and mono-nuclear trophoblasts (de Sousa et al., 2003; Garbayo et al., 
2000). Their expression undergoes spatial and temporal patterns through gestation, yet little is known of 
how PAG gene transcription is regulated. Circulating PAG concentrations in maternal blood can be 
influenced by maternal factors (i.e. weight, parity, breed), and fetal factors (i.e. birth weight, sex, number) 
(Mercadante, Ribeiro, Risco, & Ealy, 2016).  Circulating PAG concentrations are increased in twin 
pregnancies in cattle likely due to increased production that would parallel increased total binucleate 
trophoblast numbers (Garcia-Ispierto et al., 2013). 
PAGs produced by binucleated giant cells and secreted at the maternal uterine stroma are the 
basis of blood & milk pregnancy tests in ruminants. PAGs have been extensively evaluated in the 
scientific literature as a reliable tool to diagnose pregnancy in many two-toed ungulates (R. M. Wallace et 
al., 2015). Commercial assays are available and can detect PAG concentrations in both maternal blood 
and milk (Reese, Pereira, Edwards, Vasconcelos, & Pohler, 2018). Accuracy of detecting circulating 
PAGs is reported to range from 93-96% (Pohler et al., 2016).  However, spurious results can occur 
occasionally.  For example, pregnant cows with a viable embryo, with evidence of beating heart of rectal 
ultrasonography, have resulted with no detectable circulating PAGs (Pohler et al., 2015). It is unknown 
whether this situation results from a fetus not producing PAGs that can enter and accumulate in maternal 
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circulation; or if the immunoreactive assay is not specific to the circulating PAGs subset. Circulating 
PAG concentrations are highest prior to parturition and remain elevated post-partum due to a relatively 
long half-life of up to 8-10 days (R. M. Wallace et al., 2015). Pregnant sheep demonstrate a temporal; 
biphasic production of PAGs with an initial peak at gestation day 60 followed by a sharp decline by 90 
days then a steady increase culminating with parturition (Roberts, May, & Veiga-Lopez, 2017). This 
unique profile is speculated to be caused by a shifting in PAG production by the trophoblast and possibly 
the insensitivity of the diagnostic assays to detect different subsets. It is interesting to note that the initial 
decrease of PAGs in sheep corresponds when the trophoblast overtake the corpus luteum producing the 
majority of progesterone for the remainder of pregnancy.  
There are many potential functional roles of PAGs throughout pregnancy.  Speculation of PAG 
function is based on expression pattern and amount of proteolytic activity. Proteolytic PAGs produced at 
the microvillar space could process growth factors or act to disrupt the connections between trophoblast 
and uterine epithelium (Wooding, Roberts, & Green, 2005). Proteolytic activity is pH dependent; a 
decline of pH is known to occur at the fetal-maternal microenvironment around parturition(Telugu & 
Green, 2008). PAGs also may act as a bridging molecule assisting in adhesion at the maternal-fetal 
interface microenvironment (R. M. Wallace et al., 2015). PAGs produced by binucleated giant trophoblast 
can be sequestered in the maternal uterine stroma or enter maternal blood circulation. In cattle with 
retained placenta, cotyledonary PAG expression is altered compared to control cows, supporting a local 
regulatory role of PAGs in fetal membrane release (Hooshmandabbasi et al., 2018). Effects of PAGs 
influence maternal physiology and immunity at the uterus and once distributed via blood circulation could 
elicit systemic effects. In peri-parturient cattle, polymononuclear neutrophil activity is lowest at late 
gestation, which corresponds with a marked increase of circulating PAGs (Dosogne et al., 1999). 
However, correlation between occurrence of peri-parturient infectious disease and PAG concentrations in 
cattle is speculative. Yet, direct immunomodulatory effects of PAGs are not clear. Administration of 
PAGs can decrease hematopoietic cell proliferation and directly bind to uterine serpins thus augmenting 
immune responses (Mathialagan & Hansen, 1996). The immune role of uterine serpins will be discussed 
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later in this chapter. Many PAGs display increased glycosylation, which can provide some protection to 
the fetal semi-allograft by decreasing susceptibility to NK induced cell apoptosis (Perry et al., 2005). 
Experimentally, PAGs have a luteotrophic role by increasing measurable prostaglandin E2 (PGE2), which 
has direct luteotrophic and anti-luteolytic effects in ruminants thus increasing measurable progesterone 
concentration (Weems, Kim, Humphreys, Tsuda, & Weems, 2003). Progesterone, itself has 
immunomodulatory activity, which is discussed later in this review.  Furthermore, PGE2 has a direct 
immunosuppressive effect by inhibiting T-lymphocyte proliferation (P. J. Hansen & Liu, 1997).  Thus, 
PAGs can indirectly modulate immunity through the activation of other pathways that are experimentally 
defined.  
PAGs have been evaluated for their ability to serve as a marker for embryonic/fetal viability and 
placental health. Circulating PAG concentrations are lower in cattle likely to undergo embryonic/fetal 
loss. Beef cattle that maintain a pregnancy beyond 72 days of gestation have statistically higher 
circulating PAG concentration at day 28 compared to cohorts that experienced embryonic/fetal loss by 
day 72 of gestation (Pohler et al., 2013). All cows underwent transrectal ultrasonography, which 
demonstrated a viable embryo at day 28 based on fetal heartbeat. Similarly, circulating PAGs were 
decreased in beef cattle 41 days post insemination that had embryonic loss compared to cows that 
maintained their pregnancy (Perry et al., 2005). However ability to detect pregnancy loss or embryonic 
survival is assay antibody dependent (Gatea et al., 2018). Although these studies demonstrate an 
association between low PAG concentrations and fetal loss, the opposite occurs with somatic cell nuclear 
transfer (SCNT) derived embryos. Elevation in PAG levels is observed in recipient cows receiving 
SCNT-derived embryos compared with control at days 35 and 50 of gestation followed by subsequent 
fetal loss (Hashizume et al., 2002). This increase in circulating PAGs may reflect structural alteration of 
the placenta allowing increased exposure of maternal epithelia to trophoblast products such as PAGs 
(Pereira et al., 2013). PAGs have further been evaluated as a marker of placental health during 
reproductive infections.  Several studies have investigated shifting PAG concentration following 
Neospora caninum infection in cattle. Lopez-Gatius et al. determined that PAG-1 concentrations 
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decreased in aborting animals yet provided no indication of feto-placental health in chronically infected 
pregnant cattle that did not abort (Lopez-Gatius, Almeria, et al., 2007). In another study, circulating PAG-
2 concentrations of < 4.5 ng/mL at day 120 of gestation served as an indicator of abortion risk in 
chronically infected cattle (Garcia-Ispierto et al., 2013). Early PAG concentrations along with 
seroconversion to Neospora demonstrated an odd ratio of seven for abortion by 5-7 months of gestation. 
A negative correlation with other placental products such as plasma prolactin follows a similar 
relationship in the face of Neospora induced abortion (Lopez-Gatius, Almeria, et al., 2007). These data 
demonstrate that measurement of trophoblastic products such as PAG, can serve as a non-invasive marker 
of placental health, possibly indicating the occurrence of fetal mortality.  
3. Placental immunology during healthy pregnancy   
Survival of the semi-allograft conceptus is required for successful pregnancy outcome (M. B. 
Clark et al., 2007). The variety of placental types may have evolved to avoid immune rejection of the 
fetus, which is antigenically different from the dam (Hemberger, 2013). The less invasive the 
placentation, the less access of maternal immune cells will have to antigenically different fetal cells. The 
underlying mechanisms for survival and non-rejection of the fetus is not fully understood, yet several 
immunologic explanations have been proposed.  For starters, the maternal immune system may be unable 
to recognize fetal cells.  Ruminant and human trophoblast have limited expression of major 
histocompatibility complex (MHC) on its surface thus restricting the ability of immune cells to recognize 
fetal antigens (Hill, Schlafer, Fisher, & Davies, 2002; E. Meeusen, Fox, Brandon, & Lee, 1993).  Sheep 
trophoblasts appear to be totally devoid of MHC I expression following gestational day 19 (Gogolin-
Ewens, Lee, Mercer, & Brandon, 1989). MHC molecules can act as antigens themselves, and in the case 
of tissue graft or organ transplantation, T cells may recognize the tissue antigen and induce rejection. 
Thus, the lack of MHC expression by trophoblasts prevent maternal recognition by CD8+ T cells, 
ultimately preventing fetal rejection (Bainbridge, Ellis, & Sargent, 2000). Natural killer cells (NK) are 
other such innate immune cells that utilize MHC molecules and other cellular receptors including killer 
inhibitory receptors (KIRs) to recognize antigens. KIRs allow NK cells to recognize the absence of self, 
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allowing them to kill cells that fail to produce MHC. This is a critically important mechanism for 
elimination of virus-infected cells that down regulated MHC expression that would otherwise have been 
missed by CD8+ T cells.  NK are present in high number in the human and mouse decidua, and recently 
NK have been described to have increasing numbers during early pregnancy in sheep (Entrican, 2002). 
Human trophoblast appear to produce a limited amount of MHC to protect against NK induced apoptosis 
(King, Allan, et al., 2000).  With the known presence of NK in the gravid sheep uterus, it is unclear how 
fetal trophoblasts that are devoid of MHC expression avoid NK-induced apoptosis; therefore, further 
research is needed to elucidate these roles.    
The population and phenotype of uterine leukocytes is altered with normal pregnancy. In sheep, T 
cells in the uterine glandular epithelium greatly decrease in number while the number of macrophages 
increases during pregnancy (Lee, Meeusen, Gogolin-Ewens, & Brandon, 1992). Tekin and Hansen 
demonstrated that the accumulation of macrophages was due to both systemic and local signs by use of 
unilateral uterine horn ligation studies in sheep (2004). The phenotype of uterine macrophages located in 
the ruminant endometrium shifts to M2 (alternative) which function in tissue remodeling, healing, and 
immunomodulation compared to its pro-inflammatory (M1) counter parts during pregnancy (Tekin & 
Hansen, 2004). Concentrations of uterine ɣ/𝛿 T cell increase in ruminant placenta during mid and late 
pregnancy (Lee et al., 1992; E. N. Meeusen, Bischof, & Lee, 2001). CD8+ ɣ/𝛿 T cell populations are 
concentrated in the intercaruncular glandular and luminal epithelium where there is no chorionic 
attachment, limiting exposure of fetal cells to this subset of maternal immune cells (Majewski, Tekin, & 
Hansen, 2001). T cells expressing a ɣ/𝛿 receptor have less antigen specificity compared to their α/β 
counterparts (i.e. CD4+ and CD8+ T cells). Yet, CD8+ ɣ/𝛿 T cell presence at the interplacentome tissue 
suggests they control for excessive trophoblast invasion preventing danger to the dam yet minimizing 
potentially detrimental immune responses to the placenta (Fox, Lee, Brandon, & Meeusen, 1998). CD4+ 
T cells are restricted to stromal epithelium of normal pregnancy (Cobb & Watson, 1995). B cells are low 
numbers in the uterus during diestrus and concentrate in the deep stroma surrounding blood vessels 
(Pereira et al., 2013). IgG is the primary immunoglobulin produced while IgA is in higher concentrations 
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in the vagina (Cobb & Watson, 1995; Leung, Derecka, Mann, Flint, & Wathes, 2000; Mestecky, 
Moldoveanu, & Russell, 2005). Lack of B cell populations and corresponding antibodies is confirmed by 
population finding of less than 30% of multiparous cattle having anti-fetal antibodies in circulation 
following parturition. These findings describe minimal maternal leukocytes at the caruncular regions 
while number of leukocytes increase with the progression of pregnancy in the intercaruncular 
endometrium ready to recognize and processing foreign antigens of pathogenic invaders (Leung et al., 
2000). Mechanisms inducing maternal T cell tolerance to fetal cells have been described in other species. 
Human and mouse trophoblast expression indoleamine 2,3 dioxygenase is required for successful 
pregnancy with the concluded action of inhibiting CD8+ T cell function (Kudo & Boyd, 2000). Further, 
FAS ligand is expressed by human trophoblast and can induce apoptosis in activated T cells that bear 
Fas/CD95 receptor thus preventing trafficking of activated lymphocytes to the maternal-fetal interface 
(Mor, Gutierrez, Eliza, Kahyaoglu, & Arici, 1998). This supports the hypothesis of an anti-inflammatory 
giving way to a pro-inflammatory uterine environment during late term pregnancy described in many 
species (Gardner & Moffett, 2003). 
Cytokines and chemokines, produced by both maternal and fetal cells, are important mechanisms 
of communication at their interface. During diestrus and early pregnancy, the endometrial immune 
environment favors a Th2 profile (Mineo, Oliveira, Gutierrez, & Silva, 2010). Uterine CD8+ ɣ/𝛿 T cells 
in pregnant sheep express mRNA for anti-inflammatory cytokines including TGF- β, and IL-10 (Fox et 
al., 1998). Human chorionic villus trophoblasts express mRNA for both pro- and anti-inflammatory 
proteins including TNF- α, IFN- α, IL-1 β, TGF- β, and IL-10 (Bennett et al., 1999; King, Hiby, et al., 
2000). The concentration of pro-inflammatory cytokines has been confirmed at the fetal-maternal 
interface in mice using ELISAs (Jokhi, King, & Loke, 1994; Jokhi, King, Sharkey, Smith, & Loke, 1994). 
However, the effect of a pro-inflammatory milieu leading to fetal rejection is counteracted by high 
concentrations of IL-10 (Chaouat et al., 1995). Interferons, including IFNT produced by the trophoblast, 
have inherent antiviral properties and alter the function of target cells (Bazer, Song, & Thatcher, 2012). 
The function of IFNT produced by the trophoblast as a signal for maternal recognition may have evolved 
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from other type I IFNs (Ealy & Wooldridge, 2017). At the maternal fetal interface prostaglandins have a 
pro-inflammatory feature (P. J. Hansen & Liu, 1997). In vitro, ovine INFT reduced PGF2α concentrations 
confirming its antiluteolytic properties and inferring an immunosuppression role during early pregnancy 
(Chen et al., 2006; Parent, Villeneuve, Alexenko, Ealy, & Fortier, 2003). Similar to other members of the 
IFN group, IFNT has been demonstrated to have antiviral activity and inhibitory effect on lymphocytes 
(Chen et al., 2006). Thus, there appears to be a cytokine balance between pro- and anti-inflammatory 
stimuli that is critical for successful pregnancy.  
Another immune alteration during successful pregnancy is maternal immunosuppression. 
Pregnancy hormones have been demonstrated to have immunomodulatory effects.  Beyond the functions 
of establishment and maintenance of pregnancy, progesterone has many immunologic effects at the 
maternal-fetal interface. Progesterone exerts this role by influencing immune cell functionality. In humans 
and mice, progesterone plays a role in inhibiting mature dendritic cells (DCs), favoring immature DCs 
populations at the decidua.  DCs are important APCs that can activate T-cells hence having major 
influences on the immune response within tissue. Immature DCs exhibit an anti-inflammatory phenotype 
defined by increased expression of IL-10 (anti-inflammatory cytokine) and induction of T-regulatory 
cells.  Additionally, progesterone can bind to activated T-cells directly, producing progesterone induced 
blocking factor (PIBF) via signaling through the JAK/STAT pathway (Kozma, Halasz, Polgar, et al., 
2006). PIBF influences T cell and NK response, favoring a Th2 response, leading to down regulation of a 
pro-inflammatory response (Kozma, Halasz, Palkovics, & Szekeres-Bartho, 2006; Szekeres-Bartho, 
Faust, Varga, Szereday, & Kelemen, 1996). Urine concentrations of have been positively correlated with 
successful pregnancy outcomes in women (Polgar et al., 2003). Progesterone itself can induce TH2-type 
cytokine production of IL-4 and IL-10 (Monterroso & Hansen, 1993; Piccinni et al., 1995). Both IL-4 and 
IL-10 decrease TH1 and macrophage activity thus preventing allograft type rejection of the fetus. The 
shift of Th1 to Th2 response seems clinically important for maintenance of pregnancy, where woman who 
suffer from reoccurring abortion or miscarriage was associated with defective IL-4 production (Piccinni et 
al., 1995). Progesterone appears to have another indirect role for immunosuppression beyond affecting 
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uterine immune cells. Majewski demonstrated the infusion of progesterone induced secretory molecule 
release from the uterine endometrium, thought to increase maternal-fetal communication and prevent fetal 
rejection (Majewski et al., 2001). This action was independent of lymphocyte inhibition (Padua, Tekin, 
Spencer, & Hansen, 2005). It was further elucidated that progesterone induces the release of bioactive 
molecules known as serpins from uterine epithelium that have an immunoregulatory role (Liu & Hansen, 
1993; Monterroso & Hansen, 1993).   Uterine serpins in sheep have been found to inhibit lymphocyte 
proliferation and NK cell function (Liu & Hansen, 1993; Peltier, Liu, & Hansen, 2000).  Uterine milk 
protein (UTMP) a type of serpin is a progesterone glycoprotein produced by endometrium epithelium (P. 
J. Hansen & Liu, 1997). During pregnancy, UTMP is the predominant fluid in sheep uterine secretions 
(Moffatt, Bazer, Hansen, Chun, & Roberts, 1987). In-vitro, UTMP inhibits activated T cells yet in-vivo 
studies are lacking (P. J. Hansen et al., 1987). These roles elude to a progesterone-dependent 
immunomodulation of the dam during pregnancy (Arck, Hansen, Mulac Jericevic, Piccinni, & Szekeres-
Bartho, 2007). 
Another immune theory during pregnancy follows the theory that during normal, healthy 
pregnancy the semi-allogenic fetus does not propose any threat to the dam (Matzinger, 1998). This lack of 
danger signals is thought to eliminate the necessity of the maternal immune response to reject the fetus 
(Entrican, 2002). Danger associated molecular patterns (DAMPs) are signals produced by cells suffering 
from damage and non-apoptotic death. DAMPs can bind to cellular receptors such as TLRs that can 
initiate gene expression of inflammatory products.  This and many other theories speak to a multi-
mechanistic immune approach for successful pregnancy.  
4. Placental immunology during infectious disease   
The most notable infectious reproductive diseases in livestock are those that are vertically 
transmitted causing placental pathology and abortion (Entrican, Buxton, & Longbottom, 2001).  
Pathogens including Neospora caninum, Chlamydophila abortus, and bovine viral diarrhea virus 
(BVDV), will create unapparent maternal disease while manifesting severe reproductive clinical disease 
including abortion. This may be due to the inherently, anti-inflammatory immune milieu at the maternal-
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fetal interface creating an environment incapable of control or prevention of an infectious pathogen. 
Conversely, abortion maybe a consequence of the pro-inflammatory shift to Th1 environment resulting in 
immunopathology. It is important to note that mechanisms of abortion will different between pathogens. 
For the purpose of this review, select pathogens representing diverse organisms and the mechanism of 
abortion induction in ruminants will be discussed. Beyond specific pathogens, maternal physiologic 
stress, with and without disease can induce fatal consequences for the developing fetus. Stress associated 
with disease processes that activate the hypothalamic-pituitary axis inhibits the female reproductive 
system thus down regulating progesterone production, inducing spontaneous abortion (Magiakou, 
Mastorakos, Webster, & Chrousos, 1997). Cortisol release associated with inflammation can impair PAG 
production and activity (Dosogne et al., 1999). An abortion outcome may be directly associated with 
insufficient progesterone to maintain a pregnancy or the loss of progesterone-dependent immune 
modulation. Consequently, maternal stress alone is of significant consequence to the developing fetus. 
Trophoblasts express toll-like receptors (TLRs), allowing binding of specific pathogen associated 
molecular patterns (PAMPs) leading to immune-related gene expression (Takeda & Akira, 2005). The 
most expression of TLRs and thus strongest ability to recognize pathogens are found on trophoblast 
located at the chorionic villi which interdigitates with maternal endothelium (Takeda & Akira, 2005). 
Following activation, trophoblasts can produce cytokines associated with a pro-inflammatory immune 
response (Mineo et al., 2010).  Maternal uterine endothelium also recognizes PAMPs and can produce a 
variety of chemokines, cytokines, and antimicrobial compounds in response. Defensins are one such 
compound that can produced and highly conserved across species. Beta-defensins have been identified at 
the mucosal surface of the gastrointestinal, respiratory, and reproductive system of sheep (Meyerholz et 
al., 2004). Expression of these proteins is associated with bacterial and viral pathogens at these surfaces 
(Grubor, Ramirez-Romero, Gallup, Bailey, & Ackermann, 2004; Meyerholz et al., 2004). In humans, the 
endometrium produces large concentration of defensins following pathogen recognition. Further, these 
proteins can acts as chemokines for immature DC and memory T cells (Yang et al., 1999). Maternal 
immune cells within uterine tissues will also recognize pathogens. Leukocyte TLR activation is needed to 
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initiate host defenses against pathogens. Once antigens are processed APCs and presented, CD4+ 
lymphocytes secrete cytokines like IL-2 and B cells produce specific antibodies as plasma cells (Cobb & 
Watson, 1995). Yet, with maturation of APCs and NK along with pro-inflammatory cytokine production 
will affect the feto-placental units access to blood flow, nutrient exchange, and exposure to hostile, 
activated immune cells.  
C. abortus, a gram-negative bacterium, is the causative agent of ovine enzootic abortion. In non-
pregnant sheep, infection is unapparent. Infection during pregnancy results in a delayed abortion, 6-7 
weeks following the organism reaching the fetal compartment (Entrican et al., 2001). C. abortus has a 
strong placental tropism in many species. In sheep, the organism replicates in the chorionic villus 
trophoblasts.  As discussed above, the binucleate trophoblasts at the placentome create and release 
significant products required for successful pregnancy. Infected trophoblast have insufficient production 
of necessary products like progesterone. A crucial consequence of decreasing progesterone leads to 
increasing estrogen concentration, resembling a temporal hormone pattern associated induction of 
parturition. Increasing estrogen concentrations along with decreasing progesterone increases oxytocin 
activity and myometrium contraction, initiating labor. This reduction of progesterone can also result in the 
loss of the immunomodulatory benefits of this pregnancy hormone at the maternal-fetal interface. 
Resultant immunopathology of the placenta also plays a role with infectious abortion with C. abortus.  
Innate immune cells like neutrophils, not usually found in the gravid uterus, infiltrate the caruncular 
regions (Buendia et al., 1998). Neutrophils are beneficial in phagocytizing and killing the bacterium, yet 
the pro-inflammatory environment defined by the presence of cytokines such as TNF- α can have 
detrimental effects on pregnancy.  A link between IL-8 and neutrophil recruitment has been examined 
between placental endothelium damage and consequently pregnancy termination from lack of blood 
supply to the fetal compartment (D. E. Clark, Salvig, Smith, & Charnock-Jones, 1998). Consequently, the 
combined costs of C. abortus placental infection leads to fetal rejection and expulsion.  
Neospora caninum, a protozoon, is the most common cause of infectious abortion in cattle, 
worldwide (Reichel, Alejandra Ayanegui-Alcerreca, Gondim, & Ellis, 2013).  Neospora associated 
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disease and pregnancy outcomes depends on maternal immunity and stage of gestation at time of 
infection. Infection during the first trimester results in severe congenital defects in the offspring, yet risk 
of transmission to the fetus increases with gestational progression (Innes, 2007). Similar mechanisms of 
placental pathogenesis and resultant abortion are shared between N. caninum and Toxoplasma gondii, a 
cause of protozoan abortion in small ruminants (Menzies, 2011). Reproductive pathogenesis and fetal loss 
is associated with placental insufficiency (Lopez-Perez, Collantes-Fernandez, Aguado-Martinez, 
Rodriguez-Bertos, & Ortega-Mora, 2008). In cattle, placental invasion by tachzoites results in a pro-
inflammatory shift of Th1 based cell population resulting in a cytokine storm.  Although the Th1 
influenced immune response is needed to control the infection, an excess of INF-ɣ, IL-4, and IL-12 is 
detrimental toward the fetus (Arranz-Solis et al., 2016).  Following mid-gestation inoculation of pregnant 
ewes, N. caninum induced CD8+ T cell infiltrates and upregulation of INF- ɣ, IL-4, TNF- α, and IL-10 
thus depicting a mixed Th1-Th2 response. In cattle, uterine serpin expression was negatively correlated 
with IL-4 and INF- ɣ cytokine concentrations at the maternal fetal interface following N. caninum 
infection (Serrano-Perez et al., 2018). This microenvironment contributes to the observed necrotizing 
inflammation associated with placental and fetal infection (Lopez-Perez et al., 2008). Consequently, the 
large inflammatory response leading to hemodynamic changes to local tissue can further lead to fetal 
hypoxia.  Not surprisingly, the fetal trophoblast expression also changes following parasitic invasion of 
placental tissues. Bovine trophoblasts have an altered transcriptome demonstrating impaired cholesterol 
biosynthesis and extracellular matric disorganization with upregulated TLR-2 expression and cytokine 
production (Horcajo et al., 2017). Also, decreased concentration of circulating prolactin and PAG-2 have 
been associated with abortion at 5-7 months following N. caninum infection (Garcia-Ispierto et al., 2013). 
All of these factors lead to fetal morbidity and mortality following N. caninum placental infection.  
Placental pathogenesis associated with viral infections can induce fetal loss via several 
mechanisms. In the mouse, viral infection induces an upregulation of INF- ɣ, which in turn can increase 
trophoblast MHC expression (Vassiliadis & Athanassakis, 1994). This aberrant expression of MHC may 
contribute to viral pathogen associated abortion, as increased maternal INF- ɣ expression is associated 
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with spontaneous abortion (Vassiliadis & Athanassakis, 1994). Many viruses interrupt the type I IFN 
pathway following cellular infection allowing evasion of the immune cells (Baigent et al., 2002). Type I 
IFN family proteins consist of IFNT, IFN- α, IFN- β. The benefits and roles of type I IFNs in pregnancy 
successes have already been discussed in this review.   
5. BVDV fetal infections  
BVDV is a pathogen of cattle worldwide. The virus is differentiated by genotype, one and 2, now 
defined as pesitvirus A and B, and biotype, cytopathic (cp) and non-cytopathic (ncp). Both genotypes 
present with similar clinical manifestation in livestock. The biotype, immune status of the dam, and the 
stage of gestation of infection determines the outcome of reproductive BVDV induced disease. 
Subclinical disease in the dam can result in failure of conception, embryonic death, abortion, fetal 
persistent infection, congenital defects, and congenital-transient infections. Maternal peak viremia occurs 
around 7 days post inoculation (dpi) with elimination of the virus by 14 dpi.  Both phenotypes can cross 
the placental to cause fetal infection, yet only ncp BVDV viruses are capable of producing persistently 
infected (PI) offspring. In PI neonates, the viral antigen is recognized as self, limiting the type I IFN 
response needed for viral control. These animals continually shed the virus, maintaining the pathogen 
within a population. Disease associated with reproductive BVDV infection in sheep parallels what is 
observed in cattle.  
During pregnancy, acutely infected dams transmit BVDV vertically to their fetus. Although the 
dam has effectively cleared the virus, she demonstrates a compromised immune response. Viral RNA is a 
recognized PAMP triggering the innate immune response characterized by IFN response. An antiviral 
state is set into motion with IFN pathway activation, continuing with an adaptive immune response. 
Following infection spreading to the fetal compartment, dams demonstrate sustained down regulation of 
chemokine receptor 4 (CXCR4) and TCR pathways (T. R. Hansen et al., 2010; Shoemaker et al., 2009). 
CXCR4 is expressed on platelets, immune, and neuronal cells and participate in many biological 
processes most notably immune cell trafficking, and embryonic development in vasculo- and 
neurogenesis (Nagasawa, Tachibana, & Kishimoto, 1998). Down regulation of TCR pathways interferes 
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with cellular defense. BVDV antigen is not found again in maternal circulation after viral elimination 
even when carrying an infected fetus (T. R. Hansen et al., 2010). However, pregnant heifers carrying a PI 
fetus will have low, positive virus neutralization (VN) antibody titers 15 dpi which continually increase 
through 115 dpi. These data support the continual exposure of the maternal immune response to fetally 
derived virus yet local immunity prevents repeating maternal viremia. This gestational titer profile is not 
observed in heifers carrying congenital, transiently infected (CI) fetuses (T. R. Hansen et al., 2010). 
Smironova et al. described differential gene expression of circulating leukocytes of heifers carrying these 
two different populations of BVDV infected fetuses. Both groups had increased expression of interferon 
stimulated genes (ISG) including ISG15, 44, and 28; oligoadenylate synthetase 1 (OAS-1) and myxovirus 
resistance factor 2 (MX2) (Smirnova et al., 2008). Upregulated expression of these mRNA are prominent 
in innate immune responses to viral pathogen.  An upregulated type I IFN response has also been 
described in developing calves during gestation following BVDV infection (Shoemaker et al., 2009). 
Type I IFN can act as a growth-suppressive with long-term increased expression thus contributing to 
overall fetal morbidity associated with viral infection (Iwase et al., 1997). 
Following reproductive infection BVDV antigen is localized to uterine luminal and glandular 
epithelium, placentomes, and intercotyledonary fetal membranes (Fredriksen, Press, Sandvik, Odegaard, 
& Loken, 1999). BVDV antigen can also be detected in uterine macrophages and T cells (Baszler, 
Evermann, Kaylor, Byington, & Dilbeck, 1995; Fredriksen et al., 1999; Lopez, Osorio, Kelling, & Donis, 
1993). In ewes inoculated with ncp BVDV-2 isolate at 55-60 days of gestation, viral replication at the 
placentome from seven to 21 dpi was observed, with severe fibrinous ulcerative placentitis developing 
over time (Scherer et al., 2001). Binucleate trophoblasts demonstrated a larger portion of BVDV antigen 
compared to mononuclear cells (Swasdipan, Bielefeldt-Ohmann, Phillips, Kirkland, & McGowan, 2001). 
Consequently, trophoblasts suffering from BVDV infection have altered creation of need products for 
successful pregnancy including INFT and progesterone. As a type I IFN, INFT may have inherent anti-
viral properties yet the role of IFNT in BVDV infected placenta has not been elucidated (Swasdipan et al., 
2001). In ovaries from PI cattle, luteal cells are positive for BVDV antigen and resulting in altered 
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hormone production (Booth, Stevens, Collins, & Brownlie, 1995; Fredriksen et al., 1999). Luteal cell 
production of progesterone is required for maintenance of pregnancy in early gestational sheep.  
Disruption of this production can lead to pregnancy failure. We can infer that the immunomodulatory 
effects of progesterone leading to a pro-inflammatory shift at the maternal-fetal interface can also 
contribute to viral pathogenesis.  These described immune modifications following transplacental BVDV 
infection leads to intra-uterine growth restriction (IUGR) associated with placental insufficiency. 
Evidence of IUGR has been demonstrated in several studies evaluating birth weight and bone structure of 
PI versus TI and control calves (T. R. Hansen et al., 2010; Nuss et al., 2005; Webb, McGilvray, 
Smirnova, Hansen, & Norrdin, 2013). As with other infectious pathogens, placental and uterine pathology 
caused by alteration of multiple pathways results in detrimental side effects to the fetus.  
6. Exosomes – biogenesis and function  
Extracellular vesicles (EV) are produced by almost all mammalian cells. Currently EVs are 
classified based on size, content, and mechanism of production. Exosomes are one type of EV and are 
distinct in their biogenesis. Exosomes are formed with in intraluminal vesicles inside multivesicular 
bodies (MVBs). These MVBs are created from budding from the endoplasmic reticulum. Cargo 
installation into exosomes requires several steps involving endosomal proteins. Eventually, MVB fuse 
with the plasma membrane effectively dumping the exosomes via exocytosis into the extracellular space.  
Exosomes can be identified based on the presence surface marker proteins, size, and density.  Once in the 
extracellular environment, exosomes can interact with cells locally in a paracrine manner or distributed in 
circulation to act in an endocrine mode. Recipient cells can uptake exosomes via catharadin-induced 
endocytosis, phagocytosis, or pinocytosis (Tian, Wang, Wang, Zhu, & Xiao, 2010). EVs such as 
exosomes play a role in cell-to-cell communication.  Exosomes have been shown to effect a wide arrange 
of regulatory functions including immunity (Raposo & Stoorvogel, 2013). EV contain protein, nucleic 
acid, and lipid contents that can be shared with recipient cells thus imparting effects on cellular processes. 
EV can be isolated from a variety of biological fluids including serum, whole blood, milk and amniotic 
fluid in livestock and humans (G. Burns et al., 2014). Studies in humans have investigated EV content as 
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a non-invasive biomarker during disease conditions including complicated pregnancies (Hausler et al., 
2010).  
EV are believed to be a mode of maternal-fetal communication during pregnancy via transfer of 
EV contents between the conceptus and endometrium. Further, it is hypothesized that embryonic 
implantation is depended on uterine exosomes, critical for pregnancy recognition in ewes (Brooks, Burns, 
& Spencer, 2015; Ng et al., 2013; Ruiz-Gonzalez et al., 2015). Labeled maternal EV from the luminal and 
glandular epithelium traffic and interact directly with the trophoblast of the conceptus (G. Burns et al., 
2014).  It is proposed that lipid content of EV help with embryonic cell growth and other cargo may effect 
function, proliferation, adhesion and attachment. In vitro, EV stimulate trophoblast proliferation and 
IFNT production (Ruiz-Gonzalez et al., 2015). In sheep, the total number of endometrial derived EV in 
uterine lumen are positively correlated with progesterone concentration therefore helping to establish an 
embryotrophic environment (G. W. Burns et al., 2018). This concept in confirmed in women, who have 
50 fold greater exosomes in circulation during pregnancy (Salomon et al., 2016). Exosome concentration 
also increases considerable with gestational age when fetal-maternal contact surface area and blood flow 
also increase (Sarker et al., 2014).  
Several roles of EV have been proposed during healthy pregnancy.  Exosome exchange between 
the endometrium and cytotrophoblasts is associated with structural remodeling, allowing increased uterine 
blood blow during gestation (Desrochers, Antonyak, & Cerione, 2016). EV demonstrate an 
immunomodulatory role during pregnancy. Vesicles are thought to suppress maternal immunity by 
inhibiting T cell and NK activation, which are prominent in uterine endometrium during pregnancy 
(Mincheva-Nilsson & Baranov, 2014). Placental exosomes modulate cytokine release attenuating NK and 
CD8+ and ɣ/𝛿 T cells in a dose dependent manner (Hedlund et al., 2009).  Placental EV can content and 
transfer immunosuppressive messengers like syncytin-1, which decreases pro-inflammatory cytokines, 
TNF-α, and IFN-ɣ concentrations (Than et al., 2008).  It is important to remember that all activity of EVs 
is associated with their content and bioactivity. 
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Exosomes are released under both normal and pathologic conditions. Secretion of EV is altered in 
pathologic pregnancies conditions such as in pre-eclampsia (Adam et al., 2017). Furthermore, oxygen 
tensions and glucose concentrations, both indicators of placental metabolism and blood flow, influence 
EV release (Rice et al., 2015). Circulating exosome concentration is greater in pregnant woman compared 
to controls, yet pre-eclampic woman have 40% greater exosomes than women with healthy pregnancies 
(Goswami et al., 2006). This eludes to a role in maternal-fetal communication during times of placental 
disease. Utilization of EV as a form of cell-cell communication has been well described in human 
pregnancy, yet warrants further research in livestock. 
Exosomal content can be altered with viral infection. When infected with Dengue Virus, 
exosomes contain a larger amount of type I IFN based proteins needed for cellular antiviral responses 
(Zhu et al., 2015). Many RNA viruses, including HIV and PRRSV, utilize exosomes from virally infected 
cells to spread infectious viral RNA and proteins to susceptible cells (Narayanan et al., 2013; L. Wang et 
al., 2018). With the help of exosomes, HIV+ exosomes target CD4+ T cell, inducing activation, and 
making them susceptible to HIV replication (Arenaccio et al., 2014). Hepatitis A virus mimics exosome 
formation by encapsulating fully infectious viral particles into vesicles derived from endosomal 
membranes (White, Llinas-Brunet, & Bos, 2006). Within the membrane, hiding viral antigens from 
antibodies capable of neutralization.  The use of exosomes by important livestock viruses during 
reproductive pathology has not been explored.  
7. MicroRNAs during pregnancy & disease  
MircoRNAs (miRNAs) are less than 25 nucleotide base pairs in length and pay a role in gene 
expression (Reid, Kirschner, & van Zandwijk, 2011). These non-coding RNA products regulate gene 
expression by repression of translation or inducing transcript decay ultimately leading to intracellular 
silencing (Ouyang, Mouillet, Coyne, & Sadovsky, 2014). Pre-miRNA genes are transcribed and 
processed in the nucleus, then exported to the cytoplasm as an immature, stem-loop miRNA (Guo & Lu, 
2010). In the cytoplasm, they are further processed by endonucleases to form mature, short sequences 
(Hutvagner et al., 2001). There are over 1500 miRNAs identified in humans (Ouyang et al., 2014). 
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Protein or EV bound MiRNA can be isolated from blood, urine, and milk in many species including 
ruminants (Pohler et al., 2015; Reid et al., 2011).  Packaging of miRNA within the lipid bilayer of EV 
prevent breakdown by endogenous RNA-ases, perhaps increasing their effectiveness by increasing the 
likelihood of reaching recipient cells (Reid et al., 2011). Human based studies have determined 
differential abundance of specific miRNAs associated with neoplasia, sepsis, and pregnancy status (Chen 
et al., 2006; Hausler et al., 2010; J. Wang et al., 2010). Thus, miRNAs are thought to have important 
regulatory function in many tissues including the reproductive system. In immunity, miRNA profiles are 
associated with decreasing cortisol production and DAMPs signaling associated with inflammation 
eluding to an anti-inflammatory role (Fleshner & Crane, 2017). Certain miRNAs are upregulated by pro-
inflammatory pathway activation of NFκ-b in macrophages, aiding in a robust immune response 
following LPS stimulation (Taganov, Boldin, Chang, & Baltimore, 2006). Furthermore, miRNAs have 
been shown to increase granulocyte and NK activity (Mehta and Baltimore, 2016).  
Roles of miRNAs within the reproductive system are well studied in humans and more recently, 
livestock. MiRNAs have been demonstrated in ovarian function including follicular and ganulosa cell 
development (Andreas et al., 2016; Gebremedhn et al., 2015). During diestrus, progesterone appears to 
play a role in miRNA expression.  In sheep, progesterone administration altered miRNA cargo of EV 
found in the uterine lumen (G. W. Burns et al., 2018).  Progesterone-up-regulated miRNAs have been 
explored in other species as well (Cochrane et al., 2012). Burns et al. were able to characterize unique 
miRNAs within in EV associated with progesterone treatment in sheep (G. W. Burns et al., 2018). 
Pregnancy specific miRNAs have been extensively investigated in pregnant human and now more 
research is focused on this population of miRNAs in horses, cattle, and sheep (G. Burns et al., 2014; 
Klohonatz et al., 2016; Pohler et al., 2017). Burns et al. characterized EVs and miRNA profile in pregnant 
sheep in the uterine lumen and hypothesized their role in maternal-fetal communication (Brooks et al., 
2015).  Several studies have identified circulating miRNAs in cattle as potential biomarkers for early 
pregnancy detection (Ioannidis & Donadeu, 2016; Pohler et al., 2017). In humans a placenta-cluster of 
miRNAs, chromosome 19 miRNA cluster (C19MC) has been distinguished as trophoblast specific that 
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are eliminated following (Ouyang et al., 2014). Furthermore, this group of miRNAs has been 
characterized within exosomes. Expression of C19MC in trophoblast appears to be dependent on location 
and behavior, with invasive villous trophoblasts expressing more of this miRNA cluster (Xie, Han, Liu, 
Han, & Liu, 2014; Y. F. Xie et al., 2014). Greater C19MC expression correlates with maternal uterine 
stroma interaction, increasing the likelihood that miRNAs will gain access to maternal circulation. 
Chromosome 14 miRNA cluster (C14MC) are also associated with pregnancy in humans, however, 
unlike C19MC, their concentration decreases as pregnancy progresses (Ouyang et al., 2014).  Recently, 
several miRNAs were identified in serum of pregnant cattle at 24 days of gestation (Gebremedhn et al., 
2018).  These miRNAs identified shared homologous structure to C14MC miRNAs, and thought to be 
pregnancy specific.  Further research is needed to determine trophoblast specific miRNAs and quantify 
their presence in maternal circulation in livestock.  
Once in circulation, miRNAs have the ability to affect maternal physiology through gene 
silencing. The full understanding of miRNAs biological actions during pregnancy remain to be 
elucidated, however, their presence has been associated with a variety of pregnancy related 
pathophysiological conditions.  In humans, circulating miRNAs are biomarker candidates for pregnancy 
related diseases including ectopic pregnancy, intrauterine growth restriction, and eclampsia (P. Li et al., 
2013; Miura et al., 2015; Mouillet et al., 2010). Differential expression and abundance of miRNA has 
been investigated as a marker for pregnancy outcome in livestock. In cattle, differential miRNA are 
defined as markers of embryonic viability, with evidence supporting differential expression prior to 
embryonic mortality (Pohler et al., 2017). In SNCT pregnancy, overall low abundance of exosomal 
miRNAs at 21 days of gestation was associated with unsuccessful pregnancy outcome (De Bem et al., 
2017). Twenty-seven miRNAs were more abundant in SCNT pregnancy that reached term. Using gene 
ontology, the miRNAs were strongly associated with cell proliferation, angiogenesis, and embryonic 
development (De Bem et al., 2017). Based on these recent studies and the body of literature in human 
pregnancy, miRNAs have a potential to serve as a biomarker to assess pregnancy status and placental 
health yet standardization of methodology is needed.  
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MiRNAs activity in the face of viral infection has been investigated. Trophoblastic C19MC 
confer resistance to viral infection by promoting autophagy in cell culture yet concentration of miRNA 
was not influenced by viral infection in in-vivo modeling (Dumont et al., 2017)). This resistance effect 
was not observed with bacterial or protozoan challenges (Bayer et al., 2018). However, this finding has 
not been reproduced in vivo. In cell culture, bta-miR-2411 decreased BVDV replication in infected cells 
(Shi et al., 2018). MiRNAs have also been used as a mechanism for viruses to avoid host immunity.  A 
portion of the human herpes virus genome encodes for miRNAs that can be transferred to other host cells 
(Pegtel, van de Garde, & Middeldorp, 2011).  Once inside a recipient cell, viral origin miRNA act as host 
miRNAs and silence gene expression, thus down regulating IFN responses needed to control viral 
infection. With the current understanding of the role of exosomes and miRNAs in intercellular 
communication, it is not surprising that viruses would have a means to exploit this host mechanism.  
8. EV Proteomics of pregnancy  
Proteomic content in EV during pregnancy is a new field of research and thus not well described 
in published literature; however, more has been described in humans. A proteome analysis of all EV 
during the first trimester in humans revealed a protein profile involved with vesicle transport and 
inflammation, including annexin V and complement proteins (Tong et al., 2016). Jia et al performed the 
only EV proteome profile performed in abnormal pregnancy. They profiled the exosomal proteome in 
umbilical cord blood comparing healthy and pre-eclampic pregnancy (Jia et al., 2015).  Twenty-nine 
proteins were differential abundant based on disease status, demonstrating an altered expression profile of 
exosomal proteins in pre-eclampsia pregnancy possibly contributing to the pathogenesis of this condition. 
In bovine uterine exosomes during early pregnancy, 172 differentially abundant proteins were identified 
including IFNT (Kusama et al., 2018). The exosomal proteome shifted with a 1.5 fold change with 
conceptus attachment. Upregulated proteins were associated with regulation of adhesion molecule 
expression and apoptosis. Kusama et al. concluded that these exosome and their cargo are required for 
conceptus attachment (Kusama et al., 2018). Studies have evaluated change in endometrial proteome of 
pregnant sheep prior to attachment of the conceptus. Using a unilateral pregnant sheep model, 
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Arianmanesh et al. determined expression of endometrial proteins in early gestation (Arianmanesh, 
Fowler, & Al-Gubory, 2016).  Several proteins associated with metabolism and cellular adhesion, 
including apolipoptroin A and heat shock proteins were differential abundant. With what is known of the 
production and interaction of endometrial EV and corresponding nucleic acid content with the conceptus, 
investigation of EV proteome content is a worthy area of exploration.   
9. Conclusions 
Communication between the maternal and fetal tissues is critical for allow successful pregnancy.  
This is supported by the exchange of proteins, nucleic acids, biologically active lipids at this interface at 
the time of attachment and progression through a healthy gestation.  The alteration of these compounds 
are notable during times of pregnancy complications associated with infectious placental pathogenesis.  
Further exploration of these maternal and fetal products is critical to gain a full understanding of the 
milieu environment during healthy and disease pregnancy. After identification of markers associated with 
feto-placental health and pathology, mechanisms of biologic activity can be elucidating using in-vitro and 
in-vivo methodology.  Furthermore, biomarkers associated with pathologic conditions may be identified 





Alteration of pregnancy associated glycoprotein concentration in pregnant sheep infected 





Andrea Lear a, Ky Pohler b, Mee-Ja M. Sula c, Matti Kiupel d, Pierre-Yves Mulon a, Marc Caldwell a 
a Department of Large Animal Clinical Sciences and cBiomedical and Diagnostic Sciences, College of 
Veterinary Medicine, University of Tennessee, Knoxville, TN 
b Department of Animal Science, Texas A & M University, College Station, TX 
d Michigan State University Veterinary Diagnostic Laboratory, Department of Pathobiology and 
Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, MI 
 
Abstract 
Pregnancy-associated glycoproteins (PAGs) are proteins produced in large quantities from the 
placenta of even-toed ungulates. PAGs are used as a marker of pregnancy status and exhibit temporal 
expression patterns. The purpose of this study was to evaluate alterations of PAG1 concentrations in 
pregnant sheep following exposure to Bovine Viral Diarrhea Virus. Fifteen pregnant, yearling sheep were 
randomly assigned to two treatments groups. At 65 days of gestation, ewes underwent intranasal 
inoculation with 107 TCID50/mL of non-cytopathic BVDV New York-1 clinical isolate or equivalent 
volume of media for sham inoculation. Venous blood was collected at gestational day 60 and 85. At 
gestational day 85, uterine venous blood, amniotic fluid, and fetal tissue were collected via laparotomy. 
Successful fetal transmission of BVDV was confirmed with RT-PCR of fetal tissue. Blood PAG1 
concentrations were determined using a commercially available ELISA. PAG1 concentrations were 
compared between treatment group and site of collection using ANOVA analysis. PAG1 concentrations 
in jugular and uterine vein blood differed between treatment groups, with mean concentrations 
significantly lower (P =0.04 and 0.01, respectively) in BVDV inoculated dams compared to controls at 
gestational day 80. No significant concentration difference was found in amniotic fluid PAG1 
concentrations (P > 0.05).  In conclusion, infection with BVDV decreases PAG1 concentration in 
maternal circulation in pregnant sheep compared to healthy controls. Maternal PAG concentrations may 
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1. Introduction  
Bovine viral diarrhea virus (BVDV) is an economically important pathogen of livestock, 
worldwide. The reproductive outcome of BVDV fetal infection is largely dependent on the immune status 
of the dam, stage of gestation at the time of infection, biotype and virulence of the infecting virus (Kelling 
& Topliff, 2013). Data collected from a recent meta-analysis demonstrated that BVDV infection of naive 
dams during gestation results in fetal infection in greater than 95% of exposures (Newcomer, Walz, 
Givens, & Wilson, 2015). Potential reproductive sequelae include reduced conception, embryonic death, 
abortion, development of persistent infection, congenital malformations, and transient fetal infection 
(McGowan, Kirkland, Rodwell, Kerr, & Carroll, 1993). Many ungulate species are susceptible to BVDV 
infection (Passler, Ditchkoff, & Walz, 2016; Passler et al., 2014). Reproductive effects of pregnant ewes 
exposed to BVDV demonstrate similar disease progression and outcome as cattle, therefore insights into 
maternal-fetal health in the face of BVDV infection can be directly correlated (Scherer et al., 2001).  
Pregnancy associated glycoproteins (PAG) are produced by the ruminant trophoblast and 
accumulate at the microvillar junction of the placenta (R. M. Wallace et al., 2015; Wooding et al., 2005). 
The measurement of circulating PAGs in maternal blood and milk is commonly used to determine 
pregnancy status in ruminants (Commun et al., 2016; Reese et al., 2018). Although the function of PAGs 
are not fully understood, circulating concentrations have been evaluated as a biomarker of placental 
health (R. M. Wallace et al., 2015). Decreases in circulating PAG concentrations have been associated 
with embryonic loss and Neospora caninium induced abortion (Gatea et al., 2018; Pohler et al., 2013; J. 
M. Wallace, Aitken, Cheyne, & Humblot, 1997). Additionally, PAG concentrations are associated with 
abnormal placental development in dams carrying somatic cell nuclear transfer fetuses (Constant et al., 
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2011). Variations in PAG concentrations have never been evaluated in regard to reproductive viral 
infections.  
The purpose of this study was to determine the effect of BVDV fetal infection at gestational age 
85 on maternal systemic blood, uterine outflow blood, and amniotic fluid concentrations of PAG1.  Our 
hypothesis is that PAG1 concentrations in BVDV infected sheep would decrease in each compartment 
compared to sham-inoculated, pregnant controls and the ensuing decline in concentration can be used as a 
marker of fetal health.  
2. Materials and Methods 
2.1 Animals  
All animal work was approved under the guidance of the University of Tennessee Institutional 
Animal Care and Use committee (protocol 2479). Fifteen, yearling primiparous Kahtadin ewes were 
acquired from local sources and enrolled in the study. The ewes underwent estrous synchronization as 
described: an intravaginal insert containing 0.9 g progesterone (EAZI-BREED CIDR sheep insert, Zoetis 
Inc., Parsippany, New Jersey) was placed then removed after seven days, 5 mg dinoprost tromethamine 
(Lutalyse Injection, Zoetis Inc.) was intramuscularly administered at the time of removal. Ewes were 
housed with a fertile ram for natural service. Pregnancy diagnosis and confirmation using transabdominal 
ultrasound occurred at gestational day (GD) 30 and 60, respectively. At confirmation, 11 ewes exposed to 
the ram had similar pregnancy lengths at GD 60 while the remaining 4 ewes carried younger fetuses and 
were excluded from the study.  After confirmation of pregnancy, sheep were then randomly allocated 
between two treatment groups: BVDV (n = 6) or CTRL (n = 5). A larger number of experimental units 
were allotted to the BVDV group to account for expected fetal loss following inoculation. At GD 65, 
ewes received intranasal inoculation of non-cytopathic BVDV type 2 isolate NY- 1 (107 TCID50/mL) or 
equivalent volume of media to serve as sham. Blood was collected at GD 65 and 80 via jugular 
venipuncture. Whole blood was allowed to clot for 30 minutes then centrifuged at 3000 x g for 10 
minutes, then the serum removed, aliquotted and stored at – 80 0 C until analysis. At GD 80, 15 days post 
inoculation (dpi), sheep were placed under general anesthesia and hysterectomy performed. A 12 to 15 
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cm long incision was made on midline, starting immediately cranial to the udder. The linea alba was 
identified and incised to enter the abdomen. The uterine horns were carefully exteriorized and the uterine 
vein ipsilateral to the gravid horn identified to collect 3 mL of blood via catheterization with a 21 g  
butterfly catheter, afterward a fine needle aspiration of  3 mL of amniotic fluid was collected. En bloc 
resection of the complete uterus containing all fetal tissue was obtained by creating window in the broad 
ligaments to double ligate 1 cm apart the ovarian pedicle with #1 or #2 absorbable suture material (either 
polydioxanone or polyglactin sutures) before transection. The uterine body was ligated at the cervix using 
one encircling ligature and one transfixing ligature using #1 or #2 absorbable suture material before 
section of the uterine body and en bloc resection of the complete uterus. The body wall was closed in 3 
layers: peritoneum with the linea alba and subcutaneous tissues in simple continuous patterns using #1 
absorbable suture material, and the skin in a Ford interlocking pattern using #1 non-absorbable braided 
suture material (polyamide) as described by Noordsy (Noordsey, 1995). Fetal and maternal tissue where 
placed on ice and processed within 30 minutes of removal. Representative tissues of each fetus and 
placentomes were flash frozen in liquid nitrogen. All samples were then stored at -80oF until analysis. 
2.2 PAG analysis  
PAG concentrations were determined in serum originating from the jugular and uterine vein as 
well as amniotic fluid using a commercially available pregnancy specific protein B (PSPB) enzyme-
linked immunoassay (ELISA) (BioPRYN, BioTracking LLC, Moscow, Idaho).  PSPB is a placental 
protein consisting of an unknown number of PAG variants (Roberts et al., 2017). For the purpose of this 
paper, the authors will refer to PSPB as PAG1.  The ELISA assay was performed following 
manufacturer’s instructions. All samples were performed in duplicate including protein standard, non-
pregnant sheep serum and late gestation pregnant sheep serum as negative and positive controls 
respectively. Plates were read within 30 minutes of completion of the ELISA on a plate reader at 650 nm 
and concentrations estimated based on derivation from a standard curve run in duplicate with each plate. 
Standard best fit line was accepted with a fit R2 > 0.989. Mean intraassay CVs based on two quality 
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control pools were less than 3 and 5%. The interassay CVs for the same quality control pools were 2 and 
15%, respectively. 
2.3 Progesterone measurement 
Progesterone concentrations were determined on serum collected from the jugular vein at GD 85 
using commercially available radioimmunoassay (ImmuneChem Progesterone kit, MP Biomedicals, LLC, 
Orangeburg, NY). The assay was performed following manufacturer’s guidelines with an additional 15-
minute incubation period prior to centrifugation of the precipitated solution. Intra- and interassay 
coefficients of variation were both <10%. 
2.4 BVDV inoculum preparation 
Viral isolate BVDV non-cytopathic genotype 1b (pestivirus A), strain NY-1 was propagated in 
Madin-Darby bovine kidney cells in Eagle’s minimum essential medium (EMEM) containing 10% fetal 
bovine serum, L-glutamine, and penicillin G and streptomycin. Infection was induced as described by 
Walz et al. (Walz, Givens, Cochran, & Navarre, 2008). All sheep where inoculated intranasally at GD 60, 
to mimic naturally occurring maternal exposure (Swasdipan et al., 2001).  Briefly, sheep were physically 
restrained, haltered and the head elevated and stabilized.  Using a disposable intranasal cannula, sheep 
received 107 median tissue culture infective dose (TCID50) of the NY-1 isolate in EMEM (2mL 
aliquot/nostril).  
2.5 BVDV Polymerase chain reaction 
Real time polymerase chain reaction (RT-PCR) was performed as described by La Rocca and 
Sandvik on fetal tissue collected at GD 80 (15 dpi) to identify the presence of BVDV NY-1 (La Rocca & 
Sandvik, 2009).  Briefly, tissue was homogenized and RNA was isolated from samples using QIAamp 
viral RNA mini kit according to manufacturer’s instructions (Qiagen, Hilden Germany). The reverse and 
forward PCR primers for this reaction were GYGTCGAACCAYTGACGACT and 
CCATRCCCDTAGTAGGACTAGC, respectively. A TaqMan probe (TaqMan, Applied Biosystems, 
Foster City, CA) (TGGATGGCYRAABCCCTGAGT) with dye label 6-FAM on the 5’ end and Black 
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Hole Quencher (BHQ, Integrated DNA Technologies, Coralville IA) on the 3’ end. Cycle threshold (Ct) 
values over 20 were considered positive for BVDV genetic material.   
2.6 Immunohistochemistry  
Placentome tissues were fixed by immersion in 10% formalin. Tissues were routinely processed 
and, paraffin embedded. Staining for BVDV was carried out using standard immunohistochemical 
procedures developed for use in formalin fixed tissues. Five micrometer thick tissue sections were cut on 
charged slides.  Immunohistochemistry for BVD antigen was performed using the Discovery Ultra 
Automated Staining System (Roche, Ventana Medical Systems, Tucson, AZ). Briefly, following 
automated deparaffinization and antigen retrieval for 8 minutes using protease 2 retrieval solution (Roche, 
Ventana Medical Systems, Tucson, AZ) at 37 degrees, sections were incubated with a monoclonal anti-
BVD antibody that specifically targets the BVDV glycoprotein E (clone 15.C.5., Syracuse Bioanalytical, 
East Syracuse, NY, USA) at a concentration of 1:400 for 1 hour. Labeling was detected using the 
multimer based ultra-map anti-mouse detection system with a red chromogen (Roche, Ventana Medical 
Systems, Tucson, AZ). Positive controls included ear notch tissues from BVD positive cows as confirmed 
by PCR. For negative controls, the primary antibody was replaced with homologous nonimmune serum.    
2.7 Statistical analysis  
Normal distribution of data was determined using PROC UNIVARIATE. Statistical analysis was 
conducted using a one-way ANOVA using PROC GLM to test for differences in jugular vein PAG 
concentration at GD 65 and 80, taking into account time and time x treatment interactions. PROC GLM 
was used to determine difference in progesterone, amniotic fluid and uterine vein PAG concentrations. 
Pearson and ranked-Spearman correlations were determined using PROC CORR. Power of test to 
determine observations required to find equivalence between two treatments was determined using 
POWER with TWOSAMPLEMEANS and TEST=EQUIV_DIFF. Significant difference between the 
groups was considered significant when P < 0.05. All results are represented as mean with standard error 





3.1 Confirmation of BVDV fetal-infection using PCR and IHC 
Successful maternal infection and passage of BVDV into the fetal compartment was determined 
by RT-PCR. Fetal tissue collected from a single sheep assigned to the BVDV inoculated group was found 
to be negative on RT-PCR and excluded from the study leaving 5 experimental units in each treatment 
group used for final analysis. Fetal tissues from dams inoculated with virus (n = 5) were found to be 
positive on BVDV RT-PCR (mean Ct = 23.29, standard error of the mean 4.44). All fetuses of control 
sheep (n= 5) were confirmed negative for the virus on RT-PCR (Ct = 0).  
Microscopic evaluation of placentomes with hematoxylin and eosin stained slides did not identify 
any significant light microscopic differences between inoculated and control animals. In control animals, 
low numbers of mononuclear cells, predominantly lymphocytes were present in all levels of the 
endometrial stroma. In inoculated animals, the intercaruncular luminal endometrial epithelium had mildly 
increased numbers of intraepithelial mononuclear cells; however, the increase was not statistically 
significant.  BVDV antigen was detected by IHC within the trophoblastic epithelium lining 
chorioallantoic villi in all pregnant sheep inoculated with BVDV. Figure A-1 is a representative image 
from a single pregnant sheep inoculated with BVDV.   
3.2 Changes in progesterone and PAG concentrations in sheep infected with BVDV  
Mean progesterone concentrations are depicted in figure A-2. Mean progesterone concentration at 
GD 80 trended downward in BVDV infected sheep compared to CTRL (P = 0.08). No significant  
correlation was observed between progesterone concentrations and jugular PAG concentrations at GD 80 
(see figure A-3; R2 < 0.1, P = 0.13). Mean jugular PAG concentrations at GD 65 and GD 80 are depicted 
in figure A-4. Mean jugular PAG1 concentrations did not differ between treatment groups at GD 65 (P = 
0.08), but significantly diverged at GD 80, 15 dpi (P = 0.04). Serum jugular PAG1 concentration differed 
over time regardless of treatment group (P = 0.04).  Concentrations at GD 65 significantly affected mean 
PAG1 concentration at GD 80 (P = 0.03).  Mean amniotic PAG1 concentrations for BVDV (45.59 ± 
25.88 ng/mL) and CTRL (59.91 ± 22.05 ng/mL) sheep were not significantly different (P = 0.86). Mean 
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uterine vein PAG concentrations are depicted in figure A-5. Mean uterine vein PAG1 concentrations were 
significantly affected by treatment (P = 0.01) and significantly correlated using Pearson’s correlation with 
jugular PAG1 concentration at GD 80 (P < 0.01). Figure A-6 is a scatter plot displaying significant 
correlation between mean jugular and uterine vein PAG concentrations (R2 = 0.8, P < 0.01).  
4. Discussion  
The results of this study demonstrate successful experimental BVDV infection of pregnant ewes 
at GD 65 and extension of the infection to the fetus by GD 80. The effect of this infection was 
demonstrated by BVDV nucleic material found in fetal tissues and histopathologic evidence of BVDV co-
located with placental inflammation. In addition, BVDV infection resulted in a significant decrease in 
PAG concentrations associated between inoculation at GD 65 and experimental termination of the 
pregnancy at GD 80 in both maternal systemic circulation and uterine vein outflow. To the authors’ 
knowledge, this is the first description of the effects of viral pathogenesis on PAG concentrations and 
their correlation with fetal health.  
4.1 BVDV induces maternal-fetal pathology 
BVDV passage into the fetal compartment was confirmed with positive RT-PCR results in viral 
inoculated sheep. The successful inoculation method performed in this study mimics natural maternal 
exposure and resulting fetal infection in susceptible animals (Swasdipan et al., 2001). BVDV non-
cytopathic genotype 1b (pestivirus A), strain NY-1 was used for the infectious inoculation in this study.  
As a non-cytopathic biotype, this BVDV strain is capable of producing an array of reproductive sequelae 
following inoculation, including the creation of persistently infected offspring (Kelling & Topliff, 2013). 
Efficient creation of a persistently infected offspring requires passage into the fetal compartments and 
continued maintenance of pregnancy by the dam. The placental pathology observed on histopathology 
was minimal in infected dams compared to controls, yet the presence of BVDV antigen within the 
trophoblast was confirmed using IHC.  Future studies, utilizing a more virulent strain of BVDV may 
create significant placental pathology, thus altering maternal and fetal PAG concentrations even more 
dramatically.  It is important to note that no abortion associated with BVDV inoculation was observed in 
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this study. This is consistent with other studies inducing fetal disease in small ruminants with BVDV. In 
does infected with BVDV at GD 65, abortion occurred 7-65 dpi in less than 50% of inoculated animals 
(Desouky, Younis, Ahmed, & Hegazy, 2011). 
4.2 Changes in P4 and PAG concentrations with maternal-fetal BVDV infection 
Although mean serum progesterone concentrations trended lower (P = 0.08) in BVDV infected 
ewes, no significant difference was determined between infected and control sheep in this study. BVDV 
infection can result in both oophritis and fetal death with subsequent release of PGF2a from the 
endometrium, therefore it is often not clear which process has the greatest effect on serum progesterone 
(Fray, Mann, Clarke, & Charleston, 1999, 2000). Several cell types in the bovine ovary are permissive to 
BVDV, including cumulus cells, ovarian stroma, and the oocyte throughout its development, but luteal 
cells appear to be inconsistently affected (Brownlie, Booth, Stevens, & Collins, 1997; Fray, Prentice, 
Clarke, & Charleston, 1998). In non-pregnant naïve heifers, the serum progesterone and luteal tissues 
were unaffected by BVDV infection in naturally cycling heifers, however synchronized heifers 
demonstrated reduced serum progesterone during the early diestral phase and premature luteolysis (Fray 
et al., 1999; Fray, Mann, et al., 2000). Yet, any cause of embryonic loss is associated with decreased 
serum progesterone concentrations as result of indirect luteolysis (Gabor et al., 2016). Desouky et al 
described evidence of luteolysis and oophiritis as well as falling progesterone concentrations in pregnant 
does from GD 72 – 135 following inoculation at GD 65 (Desouky et al., 2011). In this report, luteloysis 
was also either induced by fetal mortality and subsequent release of PGF2a or direct pathology to the 
luteal tissue as 4 of 9 does aborted from 7 – 65 days post-inoculation. Progesterone, produced by the 
corpus luteum and eventually the placenta, is important for the establishment and maintenance of 
pregnancy (Spencer & Bazer, 2002). Moreover, the ovine placenta is the primary source of progesterone 
after 50 days of gestation (Senger, 2004). Histopathology in this study suggested minimal placentitis at 15 
dpi (GD 80), inferring that progesterone production was most likely normal in infected ewes at that time, 
but the termination of gestations makes it impossible to know if ongoing pathology would have impaired 
progesterone production at a later time point. 
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Egen et al. described a biphasic profile of PAG concentration in maternal circulation among 31 
tested ewes, where PAG concentration initially peaked at 185 ng/ml at GD 63 then decreased below 100 
ng/ml by GD 125 (Egen, Ealy, Landon, Roberts, & Green, 2009).  A similar temporal decrease was 
observed in the current study between GD 65 and 80 in both treatment groups. However, the decline 
among the BVDV infected ewes statistically exceeded that of the control ewes suggesting that by GD 80 
the infected ewes were experiencing trophoblastic injury. This observation is supported by a similar 
decrease in progesterone concentration and histopathologic evidence of placental inflammation co-located 
with BVDV antigen.  At GD 65, prior to inoculation, there was no significant difference in PAG1 
concentrations between treatment groups, supporting that the expected temporal decline was not the sole 
reason for decreasing PAG1 concentrations by GD 80. Wallace et al. also described a pattern of 
decreasing PAG concentration among pregnant ewes fed two rations during this gestational period and 
noted a sharper decrease in circulating PAG concentration among ewes experiencing non-infectious 
abortion than ewes carrying fetuses to term (J. M. Wallace et al., 1997). Likewise, other authors have 
correlated decreased PAG concentrations with embryonic loss in cattle in association with ovulatory 
follicle size, Neospora caninum infection, heat stress, high milk production, and other unidentified 
etiologies of fetal death (Garcia-Ispierto et al., 2013; Lopez-Gatius, Garbayo, et al., 2007; Mur-Novales et 
al., 2016; Perry et al., 2005; Pohler et al., 2013). In the present study, because all gestations were 
experimentally terminated at GD 80, it is not clear if the affected ewes would have demonstrated a 
continued drop in PAG concentration, ultimately indicative of ensuing abortion, or once the fetus and 
placenta had cleared the infection, PAG concentrations would have rebounded.  
Jugular venous PAG concentrations were strongly correlated with uterine vein PAG 
concentrations. As expected, the mean uterine venous PAG concentration was higher compared to jugular 
samples, indicative of dilution and or decay of PAGs upon entry into the periphery. The fate of 
peripherally circulating PAGs is unknown. Bovine PAGs have a variable half-life depending on stage of 
pregnancy and range from 21.9 hours to 10 days. Nor is it known if the half-life changes in relation to 
maternal physiology or in times of fetal stress or death. In experimentally induced, late embryonic 
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abortion, the estimated half-life of PAGs ranged 21.9 hours to 3.9 days (Pohler et al., 2013; Szenci et al., 
2003)while immediately prior to parturition half-life increased to 8-10 days (de Sousa et al., 2003). As a 
secretory product of fetal trophoblasts, several functions have been proposed.  Experimental evidence 
supports immunomodulatory actions of PAGs allowing some protection to the semi-allograft placenta (R. 
M. Wallace et al., 2015). Treatment with bovine PAG1 alters hematopoietic cell proliferation and 
endometrial chemokine production (Austin, King, Vierk, Sasser, & Hansen, 1999; Hoeben et al., 1999).  
Futhermore, uterine serpins, which directly inhibit lymphocyte proliferation, can be bound by PAGs in 
vitro thus augmenting immunomodulatory actions (Peltier et al., 2000). PAGs that accumulate in the 
maternal stroma would allow these trophoblastic products to directly influence maternal immune cells.  In 
addition to immunomodulatory roles, evidence suggests a luteotrophic action by PAGs. When treated 
with PAGs, luteal cell increase production of prostaglandin E2, which is inherently luteotrophic and anti-
luteolytic in ruminants (Weems, Lammoglia, Vera-Avila, Randel, King, et al., 1998). It is interesting to 
note that PGE2 is directly immunosuppressive, working by inhibiting lymphocyte proliferation, possibly 
an indirect mechanism of PAG immunomodulary capabilities (Low & Hansen, 1988).  Luteal cells 
exposed to PAG resulted in increased measurable progesterone, thus supporting luteal tissue function and 
thus maintenance of pregnancy (Weems, Lammoglia, Vera-Avila, Randel, Sasser, et al., 1998).  The 
effect of PAGs at the maternal-fetal interface and elsewhere in the maternal body requires further 
investigation to define their function during pregnancy. 
No significant differences in amniotic PAG1 concentrations were observed between infected and 
non-infected control groups in the current study. This finding was in contrast that of Mur-Novales et al. 
where PAG concentrations was elevated in the fetal compartments of dams infected with N. caninum 
compared to non-infected controls (Mur-Novales et al., 2016). In that study, the authors proposed that the 
increase in PAGs within fetal fluid was associated with placental damage and leakage into the fetal 
compartment. In the current study, there was minimal placentitis most likely due to the non-cytopathic 
nature and mild severity of the inoculating strain, both suggesting there was insufficient trophoblastic 
injury to induce release of PAGs in significant concentrations into fetal fluid.  
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5. Conclusions  
This is the first study investigating alterations of maternal and fetal fluid PAG concentrations 
following reproductive viral infection in ruminants. Data presented here demonstrate that BVDV 
infection results in trophoblastic injury and a significant decrease in PAG concentrations in maternal 
circulation and uterine vein blood. This indicates that circulating PAG concentrations may be used as a 
marker of placental function in the face of reproductive infection with BVDV and adds to the growing 
evidence that low PAG concentrations are correlated with placental dysfunction and fetal loss. Further 
refinement into the temporal relationship of PAG production and function with a model of fetal infection 
such as the viral model introduced here will yield future insights in evaluating these proteins as 
biomarkers of the fetal-maternal unit.  
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Abstract 
The placenta is an active immunologic organ, modulating the maternal immune response during 
pregnancy. Trophoblasts from the placenta release small membrane-bound vesicles called exosomes 
which play an important role in intercellular communication by transferring nucleic acids and proteins 
between cells. Exosomes have been found in the uterine luminal fluid within pregnant sheep, yet little is 
known of about their role in intercellular communication during pregnancy in times of health and disease. 
The hypothesis for this study states that exosomal cargo detected in maternal circulation will vary 
depending on reproductive health status and viral exposure. The specific objectives were to 1) 
characterize the profiles of circulating miRNAs in pregnant and non-pregnant sheep, and 2) determine the 
difference in exosome miRNA profiles between non-infected and BVDV-infected pregnant and non-
pregnant sheep. Twenty-three yearling ewes, found to be seronegative to BVDV on serum neutralizing 
antibody serology, were enrolled in this study. Ewes were inoculated with BVDV NY-1 or non-infective 
sham media. Fifteen days post inoculation, all animals underwent hysterectomy and peripheral blood 
collection. Exosomes were isolated using ultracentrifugation and gradient density separation.  Small RNA 
were extracted and high throughput sequencing was performed. BVDV infection status was determined 
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with BVDV RT-PCR, immunohistochemistry of fetal tissue, and virus neutralization. Statistical 
differences between circulating concentrations of miRNAs were analyzed by analysis of variance for 
repeated measures. Sixty million reads, identifying 1634 miRNAs were identified following high-
throughput sequencing. Several unique miRNAs were isolated from BVDV exposed and/or pregnant 
ewes. The identification of unique miRNAs supports the hypothesis that exosomes have a biological role 





Bovine Viral Diarrhea Virus  
Placenta  
1. Introduction 
The placenta is the bridge between the maternal and fetal tissues. The fetal trophoblasts are 
immunologically active, producing products that interact with maternal cells.  Some products include 
native molecules such as pregnancy associated glycoproteins (PAGs) and membrane protected 
extracellular vesicles containing multiple forms of bioactive molecules (Pohler et al., 2017; Pohler et al., 
2016). Exosomes are small microvesicles, 30-20 nm in size, comprised of a lipid bilayer. The production 
of exosomes form as a membrane extrusions of the endoplasmic reticulum known as a microvesiclar 
bodies (MVB) which are ultimately released into the extracellular milieu via fusion with the interior of 
the parent cell’s plasma membrane (Barile & Vassalli, 2017).  Exosomes have received more attention 
recently due to the diverse type of cells that produce them and their presence in bodily fluids (G. Burns et 
al., 2014; Vlassov, Magdaleno, Setterquist, & Conrad, 2012). Exosomal cargo generally contains 
proteins, nucleic acids, and bioactive lipids such as prostaglandins (Subra et al., 2010). The exosomal 
content activity is determined by cell or tissue of origin and suggested to be involved with intercellular 
communication thus effecting physiologic processes in recipient cells (Schorey & Bhatnagar, 2008; 
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Vlassov et al., 2012). Once released, exosomes have paracrine effects on the local cell population or more 
distant endocrine effects via peripheral circulation. The lipid bilayer surrounding exosomes serve as a 
protective shield preventing non-specific degradation of the bioactive content of small non-coding RNA 
and protein. Moreover, membrane bound proteins studding the lipid bilayer likely mediate interactions 
with target cell receptors which may drive specific or more ubiquitous messaging. Using cantharadin 
induced endocytosis, the exosomal membrane merges with the cell’s plasma membrane thereby exuding 
its contents into the cytoplasm (Barile & Vassalli, 2017).   
Exosomes have been found in venous circulation in humans, cattle, and sheep (Adam et al., 2017; 
Gebremedhn et al., 2018; Ruiz-Gonzalez et al., 2015).  Exosomal roles have been described in 
reproductive setting including conceptus attachment in cattle, and placental complications in humans (Jin 
& Menon, 2018; Kusama et al., 2018). In humans, exosomes released from trophoblasts have been 
demonstrated to carry out an important role in intercellular communication by transferring nucleic acids 
and proteins between fetal and maternal cells.  Exosomes have been discovered in uterine luminal and 
fetal fluid in sheep in times of healthy pregnancy (G. Burns et al., 2014).  However, description of 
circulating exosomes in livestock species during pregnancy associated infectious disease in absent.  
MicroRNAs (miRNAs), less than 25 bp non-coding RNA, are one of the bioactive molecules 
isolated from exosomes (Ouyang et al., 2014). These small RNA regulate gene expression by repressing 
translation or inducing transcript decay, with an overall effect of silencing gene expression and largely 
down regulating protein synthesis (Glazov et al., 2009).  Pregnancy specific miRNAs have been in 
pregnant women and recently investigated in miRNAs in horses, cattle, and sheep (G. Burns et al., 2014; 
Klohonatz et al., 2016; Pohler et al., 2017). Attempts to infer the function of miRNAs associated with 
trophoblastic exosomes has been through isolation and nucleotide sequencing which has yielded profiles 
correlating with placental health and risk of fetal morbidity and mortality in humans (J. Y. Li, Yong, 
Michael, & Gleadle, 2014; Mouillet, Ouyang, Bayer, Coyne, & Sadovsky, 2014; Ouyang et al., 2014). In 
humans, circulating miRNAs are biomarker candidates for pregnancy related diseases including ectopic 
pregnancy, intrauterine growth restriction, and eclampsia (P. Li et al., 2013; Miura et al., 2015; Mouillet 
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et al., 2010). Bovine Viral Diarrhea Virus (BVDV) is an economically important virus of artiodactyls 
worldwide (Passler & Walz, 2010). Susceptible animals infected with BVDV can suffer from a variety of 
clinical manifestations including immunosuppression, diarrhea, and an array of reproductive disease. The 
reproductive consequences seen in livestock are dependent on the stage of estrous or gestation the animals 
is exposure (Newcomer et al., 2015). Fetal infections, when coinciding with specific developmental 
timeframes, in cattle and sheep suffer from embryonic mortality, persistent fetal infection, congenital 
developmental defects, and abortion (Walz et al., 2018).  Previous studies have profiled the maternal 
cytokine production and circulating mRNA transcriptome signature at differing stages of in-utero BVDV 
infection from uterine vein blood revealing a prominent interferon response typical of viral infections (T. 
R. Hansen et al., 2010; Smirnova et al., 2014).   
In the face of viral infections, circulating exosome content and miRNAs are altered. RNA viruses, 
including human-immunodeficiency virus and porcine respiratory reproductive syndrome virus, utilize 
host cell exome production to aid in spread of viral proteins or infectious RNA to susceptible cell 
(Narayanan et al., 2013; L. Wang et al., 2018). Chromosome 19 miRNA cluster, considered the 
trophoblast specific miRNA in humans, confer viral resistance to non-placental cell in vitro (Dumont et 
al., 2017).  Recently, bovine miRNA 2411 was found to decreased BVDV replication in cell culture (Shi 
et al., 2018) 
MiRNA profiles have not been characterized during times of pathogen-associated placental 
pathology in livestock. Describing this exosomal content may help characterize reproductive viral 
pathogenesis and aid in potential biomarkers associated with placental pathology. The purpose of this 
study was to identify and describe the small RNA transcriptome from exosomes found in circulation in 
sheep. Furthermore, this study characterizes the differential miRNA expression found in relation to 
pregnancy status and BVDV exposure in sheep.   
 




All animal work was approved under the guidance of the University of Tennessee Institutional 
Animal Care and Use committee (protocol 2479). Twenty-three, yearling primiparous Kahtadin ewes 
were acquired from local sources and enrolled in the study. Fifteen ewes underwent estrous 
synchronization as described: an intravaginal insert containing 0.9 g progesterone (EAZI-BREED CIDR 
sheep insert, Zoetis Inc., Parsippany, New Jersey) was placed then removed after seven days, 5 mg 
dinoprost tromethamine (Lutalyse Injection, Zoetis Inc.) was intramuscularly administered at the time of 
removal. Ewes were then housed with a fertile ram for natural service. Pregnancy diagnosis and 
confirmation using transabdominal ultrasound occurred at gestational day (GD) 30 and 65, respectively. 
At confirmation, 11 ewes exposed to the ram had similar pregnancy lengths at GD 65 while the remaining 
4 ewes carried younger fetuses and were excluded from the study.  After confirmation of pregnancy, 
sheep were then randomly allocated between two treatment groups: PREGNANT-BVDV (n = 6) or 
PREGNANT-CTRL (n = 5). A larger number of experimental units were allotted to the BVDV group to 
account for expected fetal loss following inoculation. The remaining 8 ewes not exposed to the ram were 
randomly allocated between two additional treatment groups: NON PREGNANT-BVDV (n =4) or NON 
PRENANT-CTRL (n= 4). All Ewes received intranasal inoculation of non-cytopathic BVDV type 1 
isolate NY- 1 (107 TCID50/mL) or equivalent volume of media to serve as sham at GD 65 based on 
pregnancy confirmation. All non-pregnant ewes received intranasal viral inoculation or sham on the same 
day as pregnant ewes. Blood was collected at GD 80 or 15 days post inoculation (dpi) via jugular 
venipuncture. Whole blood was allowed to clot for 30 minutes then centrifuged at 3000 x g for 10 
minutes, then the serum removed, aliquotted and stored at – 80 0 C until analysis. At 15 dpi, all sheep 
were placed under general anesthesia and hysterectomy performed. A 12 to 15 cm long incision was made 
on midline, starting immediately cranial to the udder. The linea alba was identified and incised to enter 
the abdomen. The uterine horns were carefully exteriorized. En bloc resection of the complete uterus, 
both gravid and non gravid were obtained by creating window in the broad ligaments to double ligate 1 
cm apart the ovarian pedicle with #1 or #2 absorbable suture material (either polydioxanone or 
polyglactin sutures) before transection. The uterine body was ligated at the cervix using one encircling 
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ligature and one transfixing ligature using #1 or #2 absorbable suture material before section of the 
uterine body and en bloc resection of the complete uterus. The body wall was closed in 3 layers: 
peritoneum with the linea alba and subcutaneous tissues in simple continuous patterns using #1 
absorbable suture material, and the skin in a Ford interlocking pattern using #1 non-absorbable braided 
suture material (polyamide) as described by Noordsy (Noordsy, 1976). Fetal and uterine tissue where 
placed on ice and processed within 30 minutes of removal. Representative tissues of each fetus and 
placentomes in pregnant sheep were flash frozen in liquid nitrogen. Representative tissues of caruncular 
tissue in non-pregnant sheep were also handled as described. All samples were then stored at -80oF until 
analysis. 
2.2  BVDV inoculum preparation 
Viral isolate BVDV non-cytopathic genotype 1b (pestivirus A), strain NY-1 was propagated in 
Madin-Darby bovine kidney cells in Eagle’s minimum essential medium (EMEM) containing 10% fetal 
bovine serum, L-glutamine, and penicillin G and streptomycin. In-vivo infection was induced as 
described by Walz et al. (Walz et al., 2008). All sheep where inoculated intranasally at GD 65, to mimic 
naturally occurring maternal exposure (Swasdipan et al., 2001).  Briefly, sheep were physically restrained, 
haltered and the head elevated and stabilized.  Using a disposable intranasal cannula, sheep received 107 
median tissue culture infective dose (TCID50) of the NY-1 isolate in EMEM (2mL aliquot/nostril). Sheep 
in the control groups were handled similarly, but received a equivalent volume of media to serve as a 
sham inoculation.  
2.3 Virus neutralizing assay for BVDV 
Virus neutralization (VN) was used to detect serum antibodies against BVDV-1 and BVDV-2. 
Serum was collected for VN assay prior to inoculation and 30 dpi. The BVDV-1 cytopathic stain NADL 
and BVDV cytopathic strain 125c was used for this assay.  VN was performed as described by Walz et al. 
(Passler et al., 2014). Serum titer <1:4 was described as negative. A rising titer (4x) in paired serum 
samples collected 3 to 4 weeks apart constitutes a good basis for the diagnosis of acute BVDV infection 
(Lanyon, Hill, Reichel, & Brownlie, 2014) 
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2.3 BVDV Polymerase chain reaction 
Real time polymerase chain reaction (RT-PCR) was performed as described by La Rocca and 
Sandvik on fetal tissue collected at GD 80 (15 dpi) to identify the presence of BVDV NY-1 (La Rocca & 
Sandvik, 2009).  Briefly, tissue was homogenized and RNA was isolated from samples using QIAamp 
viral RNA mini kit according to manufacturer’s instructions (Qiagen, Hilden Germany). The reverse and 
forward PCR primers for this reaction were GYGTCGAACCAYTGACGACT and 
CCATRCCCDTAGTAGGACTAGC, respectively. A TaqMan probe (TaqMan, Applied Biosystems, 
Foster City, CA) (TGGATGGCYRAABCCCTGAGT) with dye label 6-FAM on the 5’ end and Black 
Hole Quencher (BHQ, Integrated DNA Technologies, Coralville IA) on the 3’ end. Cycle threshold (Ct) 
values over 20 were considered positive for BVDV genetic material.   
2.4 Immunohistochemistry  
Uterine and placental tissues were fixed by immersion in 10% formalin. Tissues were routinely 
processed and, paraffin embedded. Staining for BVDV was carried out using standard 
immunohistochemical procedures developed for use in formalin fixed tissues. Five micrometer thick 
tissue sections were cut on charged slides.  Immunohistochemistry for BVD antigen was performed using 
the Discovery Ultra Automated Staining System (Roche, Ventana Medical Systems, Tucson, AZ). 
Briefly, following automated deparaffinization and antigen retrieval for 8 mins using protease 2 retrieval 
solution (Roche, Ventana Medical Systems, Tucson, AZ) at 37 degrees, sections were incubated with a 
monoclonal anti-BVD antibody that specifically targets the BVDV glycoprotein E (clone 15.C.5., 
Syracuse Bioanalytical, East Syracuse, NY, USA) at a concentration of 1:400 for 1 hour. Labeling was 
detected using the multimer based ultra-map anti-mouse detection system with a red chromogen (Roche, 
Ventana Medical Systems, Tucson, AZ). Positive controls included ear notch tissues from BVD positive 
cows as confirmed by PCR. For negative controls, the primary antibody was replaced with homologous 





2.5 Progesterone measurement 
Progesterone concentrations were determined on serum collected from the jugular vein at GD 80 
or 15 dpi using commercially available radioimmunoassay (ImmuneChem Progesterone kit, MP 
Biomedicals, LLC, Orangeburg, NY). The assay was performed following manufacturer’s guidelines with 
an additional 15-minute incubation period prior to centrifugation of the precipitated solution. Intra- and 
interassay coefficients of variation were both <10%. 
2.6 Exosome isolation 
Extracellular vesicles were isolated from 2 mL of serum 15 dpi using a combination of 
centrifugation gradient isolation. Each sample was centrifuged for 15 minutes at 3000 x g and cleared 
supernatant transferred to sterile tube. Exosome precipitation was performed using a commercial kit 
according to manufacturer’s instructions (ExoQuick, System Biosciences, Palo Alto CA). Cleaned 
exosome pellets were suspended in 250 uL of PBS; 20 uL was saved for western blot analysis while the 
remainder was used for miRNA extraction described below.  
2.6.1 Western blot 
Western blots were performed as described by Pohler et al (Pohler et al., 2017).  Exosomes were 
identified for immunopositivity to surface markers Cluster of differentiation 81 (CD 81) and Heat-shock-
protein 70 (HSP 70). Both of these markers well characterized as identifiers of exosomes(Vlassov et al., 
2012). 
2.7 MiRNA extraction and validation  
Total miRNA was extracted from each biological replicate by using the miRNeasy mini-isolation 
kit (Qiagen, Germantown, MD). The quantity and quality of miRNAs were evaluated on a small RNA 
Labchip kit (Agilent Technologies, Santa Clara CA) using an Agilent 2100 Bioanalyzer according to 






2.8 Illumina RNA library preparation and sequencing  
Three experimental units per treatment group that were positive on serum exosome 
immunoreactivity for CD81 and HSP70 collected at 15 dpi were submitted for deep sequencing. All 
miRNA sequencing was performed on the Illumina Hi Seq2500 system at University of Kansas Medical 
Center Genomics Core (Kansas City, KS). All methods below have been validated and published by 
author Pohler (Pohler et al., 2017). The final volume of extracted small RNAs were converted to cDNA 
with the reverse transcriptase SuperScript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA) 
according to the manufacturer's instructions for oligo dT priming. Second-strand cDNA was then 
synthesized by following a protocol provided by Illumina; the protocol uses the Klenow fragment of 
DNA polymerase I (Illumina, San Diego, CA). The double-stranded samples were purified with a 
QIAquick PCR spin column (Qiagen). Libraries were constructed following the manufacturer’s protocol 
with reagents supplied in Illumina’s TruSeq miRNA stranded sample preparation kit. Briefly, the 
polyadenylated miRNA was purified from total RNA and fragmented. Double-stranded cDNA will be 
generated from fragmented RNA, and the index containing adapters ligated. The final construct of each 
purified library was evaluated using the Fragment Analyzer instrument, quantified with the Qubit 
fluorimeter using the quant-iT HS dsDNA reagent kit (Invitrogen), and diluted according to Illumina’s 
standard sequencing protocol for sequencing on an Illumina HiSeq 2500 sequencer. Sequence runs were 
presented as 100 bp paired-end reads.  
2.9 Statistical analysis  
Normal distribution of data was determined using PROC UNIVARIATE. Statistical analysis was 
conducted using a one-way ANOVA using PROC GLM to test for differences in mean progesterone 
concentrations. Power of test to determine observations required to find equivalence between two 
treatments was determined using POWER with TWOSAMPLEMEANS and TEST=EQUIV_DIFF. 
Significant difference between the groups was considered significant when P < 0.05. All results are 
represented as mean with standard error of the mean. All analyses were carried out using SAS version 9.4 




Read quality was verified using FastQC, a quality control program that determines base content, 
sequence quality, and adaptor content [1]. Next, the sequences were trimmed of their adaptor content 
using Skewer, a program that takes user-defined transcripts and adapter sequences and trims them based 
on the user’s parameters [2]. FastQC analysis indicated the presence of a single adaptor: the Illumina 
small RNA 3’ adaptor; using this as the sole adapter sequence, Skewer was run using mostly default 
parameters for single end trimming. Due to the smaller size of miRNAs, a minimum read length of 10 
was chosen instead of Skewer’s default of 18. One of the 12 samples was split into two files due to the 
total file size exceeding Illumina’s maximum file size; additionally, all samples were run on two lanes, 
meaning that each sample had two files corresponding to each lane. These files were concatenated into a 
single file for each sample after trimming, and FastQC was run again to confirm the removal of all 
adapter content. Based on the methods of another small RNA study in Ovis aries, the sequences were 
filtered to remove any reads with more than 30 base pairs [3]. 
The microRNA database, miRBase, contains the sequences for 106 known miRNAs annotated in 
the O. aries genome [4-8]. To determine the percentage of reads that align with these known miRNAs, 
UCSC’s BLAST-like alignment tool (BLAT) was used with special parameters to account for the smaller 
size of small RNAs [9]. In particular, the step size, or spacing between tiles, was set to 1, minimum 
sequence identity and score were set to 0, a high number of repetitions was used to avoid sequences being 
marked as “overused,” and the “fine” option was selected. Accounting for the relative small number of 
known miRNAs in O. aries, 5 additional species were used: fellow ruminants Bos Taurus (cow) and 
Capra hircus (goat), and well-annotated mammalians Mus musculus, Rattus norvegicus, and Homo 
sapiens. The design for this procedure was as follows; run BLAT to align sequences with one of the 
miRBase hairpin libraries, filter out multi-mapping reads, and filter out any reads that match with a 
miRNA. This process is repeated until reads matching any miRNA across the 6 miRNA libraries were 
identified. After filtering, each sample had six files – one for each set of miRNAs – containing a list of 
reads that aligned to known miRNAs from one of the six libraries. The filtering process ensured that no 
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read was repeated between any of the six files, and any redundant miRNAs were collapsed into a single 
instance. These files were concatenated into single files containing every known miRNA aligning to reads 
from a sample, and a custom python script was used to count every instance of a miRNA in the combined 
file and save these results to a new file. 
Two factors were used in analysis to determine differential expression: the status of the uterus 
(Non-Pregnant vs. Pregnant) and treatment with bovine viral diarrhea virus (CTRL vs. BVDV). The count 
files for the 12 samples were exported to RStudio, and analyzed using the DESeq2 and EdgeR packages 
[10-12]. DESeq2 was used to combine the individual counts files into a single data set, while EdgeR was 
used to perform a quasi-likelihood F-test to identify genes with significant differential expression. This 
analysis produced a list of miRNAs, based on EdgeR’s default adjusted p-value of 0.05 for QLF tests, that 
were deemed differentially expressed. To visualize these results through heatmaps, the reads were 
converted into log counts per million with an added count of 2 to avoid taking the log of zero. 
Additionally, the top 50 genes – ranked on their adjusted p-value with a false discovery rate of 0.1– were 
used to create Venn diagrams to identify genes unique to each treatment type. To be considered 
biologically relevant, at least 2 out of 3 sheep sequenced per group were required to have abundant 
miRNA expression defined by a count per million reads.   
To identify if samples obtained from ewes infected with BVDV contained genetic data from the 
virus, all remaining reads from the blat alignment and filtering step were aligned to the Ovis aries genome 
(assembly Oar_v4.0, 
ftp://ftp.ncbi.nlm.nih.gov/genomes/all/GCF/000/298/735/GCF_000298735.2_Oar_v4.0/GCF_000298735.
2_Oar_v4.0_genomic.fna.gz) using sensitive Bowtie2 alignment [14]. Bowtie2 produces a sequence 
alignment/map (SAM) format file that marks the number of times a read aligns to the reference genome. 
SAM Tools was used to create a separate binary SAM (BAM) file containing only reads that did not align 
to the O. aries genome, and to generate a fasta file containing the sequences of these unaligned reads [15]. 
These reads were aligned to the completed BVDV genome (GenBank: KJ689448.1) with BLAT, using 
the same parameters for short miRNA reads described above, to identify any overlap between the virus’ 
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genome and the unknown reads. In theory, the reads collected from infected ewes would contain more 
reads that overlap with the BVDV genome than those collected from healthy ewes. 
3. Results   
3.1 Confirmation of BVDV infection using VN, PCR, and IHC 
Prior to enrollment of the study, all sheep were negative (<1:4) for neutralizing antibodies to 
BVDV, confirming immunologic naivety of the animals.  All animals sham inoculated with sterile media 
remained negative (<1:4) on VN throughout the study period.  All animals enrolled in the BVDV group 
who received intranasal viral inoculation had a positive titer on VN assay 30 days following viral 
exposure. The mean titer for PREGNANT-BVDV was 1:32 (standard error of the mean (SEM) ± 6) and 
Non-Pregnant-BVDV was 1:24 (SEM ± 6). Successful maternal infection and passage of BVDV into the 
fetal compartment was determined by RT-PCR. Fetal tissues from dams inoculated with virus (n = 5) 
were found to be positive on BVDV RT-PCR (mean Ct = 23.29 ± 4.44).  All fetuses of PREGNANT-
CTRL sheep (n= 5) were negative for the virus on RT-PCR (Ct = 0).   
Microscopic evaluation of placentomes with hematoxylin and eosin stained slides did not identify 
any significant light microscopic differences between inoculated and control animals. In control animals, 
low numbers of mononuclear cells, predominantly lymphocytes were present in all levels of the 
endometrial stroma. In inoculated animals, the intercaruncular luminal endometrial epithelium had mildly 
increased numbers of intraepithelial mononuclear cells.  BVDV antigen was detected by IHC within the 
trophoblastic epithelium lining chorioallantoic villi in all PREGNANT-BVDV sheep inoculated with 
BVDV. Figure A-1 is a representative image from a single pregnant sheep inoculated with BVDV.  
Histopathology of NON PREGNANT-BVDV sheep subjectively demonstrated mild cellular infiltration 
of mononuclear cells with a mean of 17 cells compared to mean of 11 cells observed in NON 
PREGNANT CTRL sheep. BVDV antigen was not visualized in uterine tissue of any sheep in the NON 





3.2 Progesterone concentrations between treatment groups  
Mean progesterone concentrations measured 15 dpi for all treatment groups are depicted in figure 
A-7. Mean concentrations for PREGNANT-CTRL sheep (2.77 ng/ml ± 0.86) was not significantly 
different compared to PREGNANT-BVDV (1.65 ng/mL ± 0.52) and NON PREGNANT-CTRL (1.65 
ng/mL ± 0.63) (P > 0.1).  Mean progesterone concentrations for NON PREGNANT-BVDV was 
significantly lower at 0.77 ng/mL (SEM ± 0.57) compared to PREGNANT-CTRL (P = 0.01) but did not 
significantly differ compared to the remaining treatment groups (P = 0.1). 
3.3 Evaluation of isolated exosomes and miRNA content 
Exosomes were successfully isolated from circulating blood using chemical gradient 
methodology. Confirmation of exosomes isolated from serum was performed using western blot, which 
demonstrated immunostaining for exosome surface markers CD 81 and HSP 70. Figure A-8A displays a 
representative image from a sheep assigned to the PREGNANT-CTRL group demonstrating a positive 
western blot result for both CD 81 and HSP 70 along with positive and negative controls. All biologic 
replicates for each treatment group were positive for these surface markers.  Quantification of miRNAs 
were performed for each biological replicate prior to sequencing.  Mean miRNA concentration for each 
treatment group are as follows: PREGNANT-CTRL 706.96 pg/ µL (SEM ± 177.87), PREGNANT-
BVDV 525.7 pg/µL (SEM ± 46.34), NON PREGNANT-CTRL 446.53 pg/µL (SEM ± 50.96), and NON 
PREGNANT-BVDV 565.9 pg/µL (SEM ± 175.37). No significant difference was observed in miRNA 
concentration isolated for each treatment group (P > 0.5). Figure A-8B portrays Agilent electropherogram 
profiles of small RNAs extracted from circulating exosomes representative for each treatment group. 
Clustering of small RNA species below 60 base pair in all samples is indicative of the presence of 
miRNAs (Pohler et al. 2017). 
3.4 Differential abundance of miRNAs between treatment groups  
To determine the representative relative abundance of miRNAs between treatment groups, 
miRNAs were sequenced from exosomes isolated from a subset of three sheep per treatment. Deep 
sequencing of miRNA yielded 60 million reads in total with 1634 miRNAs identified. On average, 6.7 
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million raw reads were obtained per sample with 2.8 million reads containing less than 30 base pairs. The 
majority of reads mapped to bovine genome, yet miRNAs that were annotated to human, murine, ovine 
and caprine genomes were also present. BVDV RNA was not identified in the sequenced products from 
exosomes of any treatment group. Principal coordinate analysis of the total the 1634 miRNAs sequenced 
produced overlapping populations of miRNA observed within each treatment group (figure A-9). Unique 
miRNAs were detected in each treatment group and displayed in figure A-10. No miRNAs were 
consistently present across all treatment groups. Ninety miRNAs were differentially expressed between 
treatment groups. The 30 most abundant miRNAs identified that and were differentially expressed based 
on viral exposure and pregnancy status are displayed in table A-1. From these 30 miRNAs, 14 were 
differentially expressed based on exposure to BVDV and 16 miRNAs were differentially expressed by 
pregnancy status.  
4. Discussion 
This study represents the first examination of exosomal miRNA content in pregnant and non-
pregnant ruminants infected with BVDV.  Exosomes were successful isolated from maternal circulation 
using gradient methodology and confirmed with western blot. Following successful small RNA 
extraction, sequencing, and transcriptomic analysis a total of 90 miRNAs were differentially expressed 
between treatment groups defined by pregnancy status and exposure to BVDV. To the authors’ 
knowledge, this is the first study to characterize the miRNA content of exosomes produced during viral 
induced reproductive pathogenesis.   
4.1 BVDV induces maternal-fetal pathology 
Confirmation that BVDV infection was achieved following inoculation used a combination of 
RT-PCR, IHC, and VN assay results.  Seroconversion with following BVDV exposure was observed 30 
dpi. A rising titer (4x) in paired serum samples constitutes a good basis for the diagnosis of BVDV 
(Lanyon et al., 2014). Observed histologic pathology was comprised of mild infiltration of white blood 
cells to the caruncular and intercaruncular tissue.  However, no major histologic lesions were observed in 
either pregnant and non-pregnant sheep infected with BVDV. BVDV NY-1 is a relatively low virulence 
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non-cytopathic strain of BVDV which accounts for the underwhelming amount of histologic 
inflammation observed (Swasdipan et al., 2001). Perhaps the use of a more virulent strain of BVDV 
would produce a more marked appearance of local tissue inflammation. BVDV antigen was identified 
within the trophoblast in all pregnant sheep inoculated with the virus, confirming viral spread to the fetal 
compartment by 15 dpi. Viral antigen was not identified at the caruncular tissue in non-pregnant sheep 
infected with BVDV.  BVDV is known to have a proclivity for reproductive tissue including the fetal 
maternal interface and ovary (Fray, Paton, & Alenius, 2000; Swasdipan et al., 2001). In non-pregnant 
sheep blood supply to the caruncular tissue and local tissue immunity is vastly different compared to 
pregnant sheep (Swasdipan et al., 2001). This inherent difference is tissue activity may have limited the 
presence of viral replication at endometrium observed 15 dpi.  Progesterone in all sheep infected with 
BVDV trended lower than non-infected counterparts with similar reproductive status, yet no significant 
difference was observed.  These data may have suffered from type II error, where a statistically 
significant difference may have been observed with a larger sample size.  BVDV infection can result in 
both oophritis and fetal death with subsequent release of PGF2a from the endometrium, inferring that both 
processes will have an effect on serum progesterone (Fray et al., 1999; Fray, Mann, et al., 2000). 
4.2 Exosomal miRNAs are differentially expressed based on pregnancy and viral status 
Exosomes are small microvesicles comprised of a lipid bilayer. In this study, exosomes were 
isolated using a chemical gradient and were positive on western blot for exosomal surface markers CD81 
and HSP70, which are well-described exosome markers (Conde-Vancells et al., 2008).  Exosomal cargo 
generally contains proteins, nucleic acids, and bioactive lipids such as prostaglandins (Subra et al., 2010).  
MiRNAs impose their biological function by modulating gene expression by silencing mRNA leading to 
suppression of translation and thus protein synthesis (Glazov et al., 2009).  Profiles of miRNAs are being 
investigated as markers of placental health during human pregnancy (Adam et al., 2017). This study 
compared miRNA concentrations between sheep based on pregnancy status and exposure to BVDV. A 
total of 90 miRNAs were differentially expressed between treatment groups using a FDR 0.1. Of those, 
30 of the most abundant miRNAs were identified with expression difference based on pregnancy and 
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BVDV exposure in 16 and 14 miRNAs, respectively.  Several abundant miRNAs identified in this study 
are novel for differential expression for both pregnancy status and viral associated infection. Spencer et 
al. described oar-mir-19b in healthy pregnant sheep (G. W. Burns, Brooks, & Spencer, 2016).  That 
finding holds true in this study, as this miRNA is upregulated in only pregnant animals. Several miRNAs 
whose differential expression found to be determined by pregnancy status did not hold true in this study 
(Cleys et al., 2014; Ioannidis & Donadeu, 2016).  Differences between other published results may stem 
from our small number of experimental units per treatment group, thus lower the power and leading to a 
type 2 error.  Further, this study evaluated a different population of miRNAs by only sequencing 
exosomal miRNAs compared to free miRNAs in circulation. The difference in methodology may account 
for inconsistent results when trying to define miRNA profiles based on pregnancy status.   
Several miRNAs that were upregulated in the BVDV exposed group were also described in the 
literature as associated with other infectious conditions of livestock and humans. Bta-mir-2330 and bta-
mir-10225b have been associated with BHV-1 infection in bovine derived cells in vitro (Glazov et al., 
2009).  In small ruminants exposed to peste des petits ruminants, bta-mir-144 was found to be 
upregulated in the clinically ill (Pandey et al., 2017).  The miRNA has-mir-7-1 which was upregulated in 
the BVDV exposed sheep was found to be associated with reproductive viral infections in humans. Other 
differentially expressed miRNAs discovered in this study are were identified in fetal disease. For 
example, hsa-mir-674 associated with fetal alcohol syndrome is upregulated in the BVDV-infected group 
(Balaraman et al., 2014).  Fetal alcohol syndrome results in dysregulation of nutrient and oxygen 
exchange at the placental level (Balaraman et al., 2014; Balaraman, Tingling, Tsai, & Miranda, 2013). A 
similar disequilibrium can be expected in placentitis associated with infectious condition.  
Annotation of sequenced miRNA sequences was performed by aligning to several genomes 
including ovine, bovine, caprine, human, and murine.  The majority of the sequences were annotated to 
the bovine miRNA genome, yet alignment to the other aforementioned species was observed in 
differentially expressed miRNA.  Homologous structures are described between bovine and both human 
and murine miRNAs (Gebremedhn et al., 2018). However, it is unknown if the function of well-studied 
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human or murine miRNA is the same in ruminant species. A pathway analysis using mirPATH v. 3 Diana 
Tool was attempted yet the majority of bovine and ovine derived miRNA are relatively novel without 
unknown mechanisms in biologic pathways (Vlachos et al., 2015).  Prediction of miRNA targets in sheep 
published in currently literature is indirect and based on conserved sequences across multiple species (G. 
W. Burns et al., 2016).  
Viruses including PRRSV and HIV utilize exosome-mediated transport of viral RNA allowing 
cell-to-cell transmission (Arenaccio et al., 2014; L. Wang et al., 2018). Nucleic acids from BVDV 
genome were not identified in the sequenced product isolated from exosomes.  During the sequencing 
process, researchers selected for nucleic acid segments of less than 100 bp, with the hope of identifying 
miRNAs which are less than 50 bp. Narrowing the sequencing product of this size could have eliminated 
the identification of viral nucleic acids, which could be closer to 250 bp in length (Ridpath & Bolin, 
1995). Further research is needed to determine if BVDV may utilize the use of exosomes to mediate viral 
transmission.  
5. Conclusions  
MiRNAs are known to play a role in a wide range of biological processes and thus their 
expression may be disease specific making them excellent biomarkers. Many miRNAs identified in this 
study are novel and not previously described in livestock with reproductive viral infection. The miRNAs 
described in this study may provide a useful resource for future investigators to further characterize and 
select candidate miRNAs for further analysis for biological relevance.  
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Abstract 
The placenta is a transient organ, critical for growth and protection of the developing fetus. 
Trophoblasts from the fetal placenta produce a variety of products including extracellular vesicles, such 
as exosome. Exosomes have been found in pregnant sheep, yet little is known of about their role in 
maternal-fetal communication during pregnancy during times of health and disease. The hypothesis of 
this study states that exosomal proteome detected in maternal circulation will vary depending on 
reproductive health status and viral exposure. The specific objectives were to 1) characterize the profiles 
of circulating exosomal proteins in pregnant and non-pregnant sheep, and 2) determine the differential 
abundance in proteome between non-infected and BVDV-infected pregnant and non-pregnant sheep. 
Twenty-four yearling ewes, found to be negative to BVDV on serum neutralizing antibody serology, were 
enrolled in this study. Ewes were inoculated with BVDV NY-1 or sham media. Fifteen days post 
inoculation, all animals underwent hysterectomy and peripheral blood collection. Exosomes were isolated 
using ultracentrifugation and gradient density separation.  Mass spectroscopy proteomics were performed 
and predicted protein forms identified using Proteome Discoverer Percolator. BVDV infection status was 
determined with BVDV PCR of fetal tissue. Statistical differences between abundance of proteins were 
analyzed of variance for repeated measures.  With a confidence rate of 0.01, 539 proteins were identified 
with differential relative abundance between viral exposure. This studies supports the idea that exosomes 
containing select proteins are present in peripheral circulation likely have a biological role in fetal-







Bovine Viral Diarrhea Virus  
Placenta  
1. Introduction 
The placenta is an essential organ needed for growth and survival of the fetus.  Maternal-fetal 
cellular communication is critical to maintain a healthy pregnancy, and any dysfunction can result in fetal 
morbidity or mortality (Adam et al., 2017). Exosomes (30-150 nm particles) are released from various 
types of cells and can serve as communication channels between the dam and fetus (Jin & Menon, 2018).  
In sheep production of exosomes is associated with progesterone production, with higher concentration of 
vesicles isolated during pregnancy compared to non-pregnant sheep (G. W. Burns et al., 2018). This 
concept in confirmed in women, who have 50 fold greater exosomes in circulation during pregnancy 
(Salomon et al., 2016). Exosomal cargo comprised of proteins, lipids, and nucleic acids. Once released 
from the parent cell, exosomes cause a function change in recipient cells dependent on their contents 
(Barile & Vassalli, 2017).  Studies in human pregnancy have linked exosomal content with placental 
dysfunction, leading health complications for the fetus and dam(Jin & Menon, 2018). Examination of 
exosomal content in livestock is limited, with a narrow scope evaluating only normal, uncomplicated 
pregnancy (G. W. Burns et al., 2016). Proteomic evaluation of exosomes in pregnancy is relatively novel 
with only a few publish reports in humans. Jia et al described differentially abundant proteins in cord 
blood isolated from pre-eclampic woman compared to healthy controls (Jia et al., 2015). Characterization 
of the protein contents of exosomes may help elucidate pathophysiologic mechanism during complicated 
pregnancies.  
Bovine viral diarrhea virus (BVDV) is a positive sense, RNA virus that affects all even-toed 
ungulates (Passler & Walz, 2010). It is an economically important virus of livestock, worldwide, and can 
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yield dramatic reproductive pathology resulting in failure to conceive, embryonic death, persistent fetal 
infection, congenital fetal infection, and abortion (Newcomer et al., 2015). The virally induced pathology 
at the maternal fetal interface tissue has been investigated using histopathology, protein arrays, and 
mRNA transcription (T. R. Hansen et al., 2010; Smirnova et al., 2012; Smirnova et al., 2014). Other RNA 
viruses, including HIV and PRSSV, have been demonstrated to alter exosome production and content in 
infected cells (Narayanan et al., 2013; L. Wang et al., 2018). However, this viral mechanism has not been 
evaluated in relation to BVDV infection. Examination of exosomal content may further elucidate viral 
pathogenic mechanism during pregnancy in livestock.  
Proteome profiling of circulating exosomes in pregnant animals is needed to better understand 
placental immunology in times of health and disease. With the hypothesis that the exosomal proteome 
would vary based on pregnancy and viral exposure status, we set out with the specific objectives to 1) 
characterize the profiles of circulating exosomal proteins in pregnant and non-pregnant sheep, and 2) 
determine the difference in exosome profiles between non-infected and BVDV-infected pregnant and 
non-pregnant sheep.  
2. Materials and Methods 
2.1 Animals 
All animal work was approved under the guidance of the University of Tennessee Institutional 
Animal Care and Use committee (protocol 2479). Twenty-four, yearling primiparous Kahtadin ewes were 
acquired from local sources and enrolled in the study. The ewes underwent estrous synchronization as 
described: an intravaginal insert containing 0.9 g progesterone (EAZI-BREED CIDR sheep insert, Zoetis 
Inc., Parsippany, New Jersey) was placed then removed after seven days, 5 mg dinoprost tromethamine 
(Lutalyse Injection, Zoetis Inc.) was intramuscularly administered at the time of removal. Ewes were 
housed with a fertile ram for natural service. Pregnancy diagnosis and confirmation using transabdominal 
ultrasound occurred at gestational day (GD) 30 and 60, respectively. At confirmation, 11 ewes exposed to 
the ram had similar pregnancy lengths at GD 65 while the remaining four ewes carried younger fetuses 
and were excluded from the study.  After confirmation of pregnancy, sheep were then randomly allocated 
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between two treatment groups: BVDV (n = 6) or CTRL (n = 5). A larger number of experimental units 
were allotted to the BVDV group to account for expected fetal loss following inoculation. At GD 65, 
ewes received intranasal inoculation of non-cytopathic BVDV type 2 isolate NY- 1 (107 TCID50/mL) or 
equivalent volume of media to serve as sham. Blood was collected at GD 80 via jugular venipuncture. 
Whole blood was allowed to clot for 30 minutes then centrifuged at 3000 x g for 10 minutes, then the 
serum removed, aliquotted and stored at – 80 0 F until analysis.  
2.2  BVDV inoculum preparation 
Viral isolate BVDV non-cytopathic genotype 1b (pestivirus A), strain NY-1 was propagated in 
Madin-Darby bovine kidney cells in Eagle’s minimum essential medium (EMEM) containing 10% fetal 
bovine serum, L-glutamine, and penicillin G and streptomycin. Infection was induced as described by 
Walz et al. (Passler et al., 2007). All sheep where inoculated intranasally at GD 65, to mimic naturally 
occurring maternal exposure (Swasdipan et al., 2001). Briefly, sheep were physically restrained, haltered 
and the head elevated and stabilized.  Using a disposable intranasal cannula, sheep received 107 median 
tissue culture infective dose (TCID50) of the NY-1 isolate in EMEM (2mL aliquot/nostril).  
2.3 BVDV Polymerase chain reaction 
Real time polymerase chain reaction (RT-PCR) was performed as described by La Rocca and 
Sandvik on fetal tissue collected at GD 80 (15 dpi) to identify the presence of BVDV NY-1 (La Rocca & 
Sandvik, 2009).  Briefly, tissue was homogenized and RNA was isolated from samples using QIAamp 
viral RNA mini kit according to manufacturer’s instructions (Qiagen, Hilden Germany). The reverse and 
forward PCR primers for this reaction were GYGTCGAACCAYTGACGACT and 
CCATRCCCDTAGTAGGACTAGC, respectively. A TaqMan probe (TaqMan, Applied Biosystems, 
Foster City, CA) (TGGATGGCYRAABCCCTGAGT) with dye label 6-FAM on the 5’ end and Black 
Hole Quencher (BHQ, Integrated DNA Technologies, Coralville IA) on the 3’ end. Cycle threshold (Ct) 
values over 20 were considered positive for BVDV genetic material.   
2.4 Immunohistochemistry  
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Placentome tissues were fixed by immersion in 10% formalin. Tissues were routinely processed 
and, paraffin embedded. Staining for BVDV was carried out using standard immunohistochemical 
procedures developed for use in formalin fixed tissues. Five micrometer thick tissue sections were cut on 
charged slides.  Immunohistochemistry for BVD antigen was performed using the Discovery Ultra 
Automated Staining System (Roche, Ventana Medical Systems, Tucson, AZ). Briefly, following 
automated deparaffinization and antigen retrieval for 8 minutes using protease 2 retrieval solution (Roche, 
Ventana Medical Systems, Tucson, AZ) at 37 degrees, sections were incubated with a monoclonal anti-
BVD antibody that specifically targets the BVDV glycoprotein E (clone 15.C.5., Syracuse Bioanalytical, 
East Syracuse, NY, USA) at a concentration of 1:400 for 1 hour. Labeling was detected using the 
multimer based ultra-map anti-mouse detection system with a red chromogen (Roche, Ventana Medical 
Systems, Tucson, AZ). Positive controls included ear notch tissues from BVD positive cows as confirmed 
by PCR. For negative controls, the primary antibody was replaced with homologous nonimmune serum.    
2.5 Exosome isolation 
Extracellular vesicles were isolated from 2 mL of serum 15 dpi using a combination of 
centrifugation gradient isolation. Each sample was centrifuged for 15 minutes at 3000 x g and cleared 
supernatant transferred to sterile tube. Exosome precipitation was performed using a commercial kit 
according to manufacturer’s instructions (ExoQuick, System Biosciences, Palo Alto CA). Cleaned 
exosome pellets were suspended in 250 uL of PBS; 20 uL was saved for western blot analysis while the 
remainder was used for proteomic analysis described below.  
2.5.1 Western blot 
Western blots were performed as described by Pohler et al (Pohler et al., 2017).  Exosomes were 
identified for immunopositivity to surface markers Cluster of differentiation 81 (CD 81) and Heat-shock-
protein 70 (HSP 70). Both of these markers well characterized as identifiers of exosomes (Conde-
Vancells et al., 2008).   
2.6 Mass spectroscopy  
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Each multidimensional protein identification technology (MudPIT) fraction was subjected to in-
line Reverse Phase (RP) chromatography and tandem mass spectrometry to identify proteins in each 
fraction. Briefly, each sample was loaded onto a C18 nano column using a Thermo Scientific RSLCnano 
system. The flow rate was 200nl/min. Peptides were eluted from the column using a linear acetonitrile 
gradient from 2 to 80% acetonitrile over 180 minutes followed by high and low organic washes into an 
Orbitrap Fusion Lumos mass spectrometer (Thermo Scientific) via a nanospray source. The spray voltage 
was set to 1.8kV and the ion transfer capillary was set at 275°C. A data-dependent Top 10 method was 
used where a full MS scan from m/z 350-1600 was followed by MS/MS scans on the 10 most abundant 
ions.  Data dependent MS/MS data was collected using a collision induced dissociation(CID) energy of 
35%, at a scan range of 400-1200m/z, and using higher energy collision dissociation (HCD) energy of 
65% with a scan range of 100-500 m/z. A dynamic exclusion of 60s was set. 
2.7 Statistical analysis  
Raw data files were searched against the most recent database for Ovis Aries downloaded from 
NCBInr using the MudPIT option in Proteome Discoverer 2.2 (Thermo Scientific) and the Sequest HT 
search algorithm. For protein identification results, only peptides identified with high confidence were 
used. Trypsin was the selected enzyme allowing for up to two missed cleavages per peptide. 
Carbamidomethylation of cysteine, N-terminal TMT6-plex, and Lysine TMT6-plex were used as a static 
modifications whereas oxidation of Methionine and TMT6-plex of Threonine were used as variable 
modifications. For confidence, the Percolator algorithm was used for peptide-spectrum match (PSM) 
validation in database searches. The False Discovery Rate (FDR) threshold calculated in Proteome 
Discoverer Percolator (Thermo Fischer Scientific, Waltham, MA) when high confidence peptides was 
used for protein identification is 0.01. The relative abundance of identified proteins in each sample was 
determined by calculating the ratios in pairwise comparisons using SAS version 9.4 (SAS Institute Inc., 
Cary, NC).  Graphical representation of proteome distribution via scatter plot and up and down regulated 




3. Results  
3.1 Confirmation of BVDV infection using VN, PCR, and IHC 
Prior to enrollment of the study, all sheep were negative (<1:4) for neutralizing antibodies to 
BVDV, confirming immunologic naivety of the animals.  All animals undergoing sham inoculation with 
media remained negative (<1:4) on VN 1 month following intranasal inoculation.  All animals enrolled in 
the BVDV group who received intranasal viral inoculation had a positive titer on VN assay 1 month 
following viral exposure. The mean titer for PREGNANT-BVDV was 1:36 (standard error of the mean 
(SEM) ± 6) and Non-Pregnant-BVDV was 1:24 (SEM ± 6). A rising titer (4x) in paired serum samples 
constitutes a good basis for the diagnosis of BVDV (Lanyon et al. 2014). Successful maternal infection 
and passage of BVDV into the fetal compartment was determined by RT-PCR. Fetal tissues from dams 
inoculated with virus (n = 5) were found to be positive on BVDV RT-PCR (mean Ct = 23.29 ± 4.44).  All 
fetuses of PREGNANT-CTRL sheep (n= 5) were negative for the virus on RT-PCR (Ct = 0).   
Microscopic evaluation of placentomes with hematoxylin and eosin stained slides did not identify 
any significant microscopic differences between inoculated and control animals. In control animals, low 
numbers of mononuclear cells, predominantly lymphocytes, were present in all levels of the endometrial 
stroma. In inoculated animals, the intercaruncular luminal endometrial epithelium had mildly increased 
numbers of intraepithelial mononuclear cells.  BVDV antigen was detected by IHC within the 
trophoblastic epithelium lining chorioallantoic villi in all PREGNANT-BVDV sheep inoculated with 
BVDV. Figure A-1 is a representative image from a single pregnant sheep inoculated with BVDV.  
Uterine tissue from NON PREGNANT-BVDV was not positive for BVDV antigen on IHC.  
3.2 Evaluation of isolated exosomes  
Exosomes were successfully isolated from circulating blood using chemical gradient 
methodology. Confirmation of exosomes isolated from serum was performed using western blot, which 
demonstrated immunostaining for exosome surface markers CD 81 and HSP 70. Figure A-11 displays a 
representative image from a sheep assigned to the PREGNANT-CTRL group demonstrating a positive 
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western blot result for both CD 81 and HSP 70 along with positive and negative controls. All biologic 
replicates for each treatment group were positive for these surface markers.   
3.4 Differential proteome content between treatment groups  
Briefly, 539 proteins were identified as high confidence peptides. When high, medium and low 
confidence peptides are considered the total number of identified proteins increases to 694. Figure A-12 
depicts a volcano scatter plot representing the distribution of proteome data discovered with high 
confidence between treatment groups.  Twenty proteins identified were significantly abundant (P < 0.05) 
between treatment groups. Table A-2 displays these significant proteins and the TMT ratios used in 
estimating the relative concentration of each identified protein in samples. A fold-change threshold of 1.5 
is used for up/down regulation, a TMT Ratio >1.5 is classified as up-regulated, and a ratio <0.67 is 
classified as down- regulated. Ratios from 0.67 – 1.5 are considered moderate to no changes. Ratios 
above 100 exceed the maximum allowed threshold that is reasonably expected. Pathway analysis 
determined biological and cellular processes of proteins found to be differentially abundant based on 
BVDV exposure; these are depicted in figure A-13 and A-14. Pathways associated with immunologic 
processes, enzymatic regulation, protein binding and metabolic processes were upregulated in animals 
exposed to BVDV. Notably, antioxidant activity, and catalytic activity, and defense responses were down 
regulated with BVDV exposure.  
4. Discussion 
This study was successful in describing the proteome of circulating exosomes isolated from sheep 
exposed to BVDV. Further, this is study is novel in describing the circulating exosomal proteome in 
apparently healthy pregnant and non-pregnant sheep. Following successful isolation of circulating 
exosomes, 539 proteins were identified with high confidence. To the authors’ knowledge, this is the first 
description of the effects of viral reproductive pathogenesis on exosomal proteome profiles in livestock. 
4.1 BVDV induces maternal-fetal pathology 
Confirmation that BVDV infection was achieved following inoculation used a combination of 
RT-PCR, IHC, and VN assay results.  Observed histologic pathology was comprised of mild infiltration 
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of white blood cells to the caruncular and intercaruncular tissue.  However, no major histologic lesions 
were observed in either pregnant and non-pregnant sheep infected with BVDV. BVDV NY-1 is a 
relatively low virulence non-cytopathic strain of BVDV which accounts for the underwhelming amount 
of histologic inflammation observed (Swasdipan et al., 2001). Perhaps the use of a more virulent strain of 
BVDV would produce a more marked appearance of local tissue inflammation. BVDV antigen was 
identified within the trophoblast in all pregnant sheep inoculated with the virus, confirming viral spread to 
the fetal compartment by 15 dpi. Viral antigen was not identified at the caruncular tissue in non-pregnant 
sheep infected with BVDV.  BVDV is known to have a proclivity for reproductive tissue including the 
fetal maternal interface and ovary (Fray, Mann, et al., 2000; Swasdipan et al., 2001). In non-pregnant 
sheep blood supply to the caruncular tissue and local tissue immunity is vastly different compared to 
pregnant sheep (Swasdipan et al., 2001). This inherent difference is tissue activity may have limited the 
presence of viral replication at endometrium observed 15 dpi.   
4.2 Exosomal proteins are differentially abundant based on viral exposure status 
Many of the exosomal proteins identified are known to be associated with innate immunity and 
inflammation, including fibrinogen and complement. Other than its role in coagulation, fibrinogen is an 
acute phase protein produced by the liver during acute inflammation (Davalos & Akassoglou, 2012). 
Several other acute phase proteins including haptoglobin, C-reactive protein, and serum amyloid A were 
found to be abundant within BVDV exposure sheep yet significantly (data not shown). Complement 
proteins are produced constitutively, yet production can be increased during inflammation (Daha & van 
Kooten, 2016). These proteins aid in opsoninzation of antigens and direct killing of microbial pathogens 
via complement complex formation.  Other abundant proteins included proteins associated with the innate 
immune arm such as immunoglobulin segments. Variable portions of immunoglobulins are upregulated in 
pregnant BVDV inoculated animals compared to non-pregnant.  B-lymphocytes are the producers of 
circulating immunoglobulins. Further, this cell type are avid producers of exosomes during inflammation 
(Saunderson & McLellan, 2017).  The fact that the variable light chain was abundant without the presence 
of the constant heavy chain indicated the smaller, antigen-binding portion of the immunoglobulins was 
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selectively being released.  The presence of this profile of proteins supports a humoral immune response 
following BVDV infection.  The production of neutralizing antibodies is also supported by the VN titer 
increase 30 days following experimental infection with BVDV. Concurrent peak viremia and viral 
shedding of BVDV is expected to occur at 7 dpi, with resolution of viral shedding by 14 dpi (Grissett, 
White, & Larson, 2015). This study looked at samples at 15 dpi, yet evidence of acute inflammation was 
still present in the exosomal proteome of BVDV infected animals.  In pregnant animals, the fetus and 
trophoblast had confirmed presence of BVDV antigen, perhaps serving as a nidus of ongoing acute 
inflammation.   
Retinol binding protein 4 was down regulated in animals exposed to BVDV compared to 
controls.  Recent literature describes the role of retinol binding proteins inducing pro-inflammatory 
response by T lymphocytes (Zabetian-Targhi, Mahmoudi, Rezaei, & Mahmoudi, 2015).  It is interesting 
that this protein would be down regulated in the face of induced inflammation associated with 
experimental infection.  Following acute BVDV, transient lymphopenia is observed 3-9 dpi, with 
peripheral numbers recovering by 14 dpi (Falkenberg, Dassanayake, Neill, & Ridpath, 2017). BVDV has 
a cellular tropism for lymphocytes and that cellular proclivity may thus interfere with lymphocyte 
inflammatory response inducing immunosupression (Chase, Elmowalid, & Yousif, 2004; Howard, 1990).  
The down regulation of this effector protein may represent a novel mechanism of immunosuppression 
induced by BVDV infection. 
Different forms of serpins were present and had a variable abundance pattern in BVDV infected 
animals. Serpins are produced by the endometrium and appear to be progesterone dependent. Uterine 
serpins’ mechanism of immune modulation during pregnancy was recently reviewed (Padua et al., 2005). 
Serpin acts to down regulate immune cells, by inhibiting lymphocyte responses against the fetus, thus 
inducing an anti-inflammatory environment at the maternal fetal interface during pregnancy (Liu, 
Gottshall, & Hansen, 1997). The role of serpins during infectious placental pathology are less described.  
One recent study described a negative association between Neospora caninum antibody titers and serpin 
expression within the bovine placenta (Serrano-Perez et al., 2016).  Furthermore, bovine uterine serpin 
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concentrations are negatively correlated with interferon expression following N. caninum infection 
(Serrano-Perez et al., 2018). In reproductive infection of naive cattle carrying fetuses transiently or 
persistently infected with BVDV, interferon associated genes and interferon cytokines were elevated at 
the maternal fetal interface and in maternal circulation compared to controls (Smirnova et al., 2014). With 
the complex abundance pattern of serpins observed in this study, placental viral infection may disrupt the 
immunosuppressive function of uterine serpin.    
Several alpha-glycoproteins were up regulated in BVDV infected sheep. The binucleate 
trophoblasts of pregnancy ruminants produce a variety of products including pregnancy-associated 
glycoproteins (PAGs) (R. M. Wallace et al., 2015). Trophoblast are known to produce exosomes in many 
species, indicating that PAGs may be present within these exosomes found in maternal circulation (Adam 
et al., 2017; G. Burns et al., 2014). However, the predicted molecular structure of PAGs would need to 
compared with the other glycoproteins discovered in this study to confirm this postulate.  Histidine rich 
glycoprotein was observed to be down regulated in pregnant sheep exposed to BVDV. Lower circulating 
concentrations of this protein is associated with pre-eclampsia in women (Bolin, McClurkin, Cutlip, & 
Coria, 1985).  Exosome concentrations and content has been extensively investigated in human as 
biomarkers to predict pre-eclampsia in women (Adam et al., 2017). Total numbers of circulating 
exosomes is greater in pregnant woman compared to controls, yet pre-eclampic woman have 40% greater 
exosomes than women with healthy pregnancies (Goswami et al., 2006). For this study, the total 
concentration of exosomes was not determined between treatment groups.  
Many forms of apolipoproteins were identified within treatment groups. This finding is expected 
since the composition of exosomes is a lipid bilayer (Subra et al., 2010).  In addition, the method of 
isolated exosomes may yield other lipoprotein contamination from the lipid fraction of the blood (Karimi 
et al., 2018). Apolipoprotein C III, which was downregulated in BVDV infected sheep, is active in the 
peroxisome proliferator-activated receptors signaling pathway (PPAR) (Lui et al 2015). PPAR have been 
demonstrated to play a significant role in human placentogenesis and a disruption of this signaling 
pathway is thought to contribute to pathologic pregnancy conditions such as preeclampsia and intra-
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uterine growth restriction (Ruebner et al., 2012).  The dysregulation of this pathway is a possible novel 
mechanism of BVDV-induced placental inflammation.  
5. Conclusions  
This is the first study profiling the proteome of exosomes isolated from pregnant and non-
pregnant sheep exposed to BVDV.  Differentially abundant proteins described in this study give insights 
into novel mechanisms of immunosuppression and placental pathology not previously described with 
BVDV infection.  These data will serve future studies in helping to define placental immunity during 
times of health and disease.  
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Communication between the maternal and fetal tissues is critical for allow successful pregnancy.  
This is supported by the exchange of proteins, nucleic acids, biologically active lipids at this interface at 
the time of attachment and progression through a healthy gestation.  The alteration of these compounds 
are notable during times of pregnancy complications associated with infectious placental pathogenesis.  
Further exploration of these maternal and fetal products is critical to gain a full understanding of the 
milieu environment during healthy and disease pregnancy. After identification of markers associated with 
feto-placental health and pathology, mechanisms of biologic activity can be elucidating using in-vitro and 
in-vivo methodology.  These data collected in this body of work serve as foundational research to answer 
mechanistic questions of placental pathology. Furthermore, these works looked to identify biomarkers 
associated with pathologic conditions that may be used to assess placental health during gestation. 
These data presented are the first investigating alterations of maternal and fetal fluid PAG 
concentrations following reproductive viral infection in ruminants. Our study supports that trophoblastic 
injury associated with BVDV infection caused a significant decrease in PAG concentrations in maternal 
circulation. This indicates that circulating PAG concentrations are a useful marker of placental function in 
the BVDV infection and adds to the growing evidence that low PAG concentrations are correlated with 
placental dysfunction and fetal loss with reproductive infections. Comparing PAG concentrations between 
dams carrying PI and CI fetuses may demonstrate a pattern of trophoblastic injury through gestation. 
Further characterization of the relationship between temporal PAG production using a fetal infection 
model such as the viral model introduced here will yield future insights in evaluating these proteins as 
biomarkers of the fetal-maternal unit. This is also the first study to compare PAG concentrations between 
maternal jugular and venous blood. Further studies evaluating dilution or removal of PAG from systemic 
circulation may elucidate sites beyond the uterine environment where PAG may exert novel function.  
These were the first studies defining circulating exosomal content in pregnant and non-pregnant 
animals exposed to a viral pathogen.. Many miRNAs identified our study are novel and not previously 
described in livestock in reproductive viral infection and healthy pregnancy. Using the information 
gleaned from this and publish work, a list of potential miRNAs that are biologically relevant during both 
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healthy and pathology pregnancies can be created. Future studies using cell culture and infection models 
like the one described here can help define the biologic impacts on trophoblasts and maternal cells. The 
miRNAs described in this study may provide a useful resource for future investigators to further 
characterize and select candidate miRNAs for further analysis for biological relevance. However, the 
need for standardized methodology for miRNA isolation and annotation will better the current and future 
databases allowing accurate available information.  Defining the proteome of exosomes during pathologic 
pregnancies is relatively novel, with few published reports to date. In our study, differentially abundant 
proteins were discovered between infected and non-infected animals. This data gives insights into novel 
mechanisms of immunosuppression and placental pathology not previously described with BVDV 
infection.  These data will serve future studies in helping to define placental immunity during times of 
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Figure 1:  
Representative image of the maternal-fetal interface (placentome), BVDV inoculated animal, 80 days of 
gestation. The chorioallantois (*) is lined by plump trophoblastic epithelium which is multifocally 
immunopositive (arrows) for BVDV. The maternal endometrium (ǂ) interdigitates with the chorioallantois 









Figure 2:  
Mean progesterone concentrations (ng/mL) (mean ± SEM) of control and BVDV inoculated ewes at 
gestational day (GD) 80. No significant difference was determined, denoted as # (P = 0.08). SEM, 































Figure 3:  
Pearson’s correlation plots between progesterone and PAG1 concentrations between control (open 
































Mean serum PAG1 concentration (ng/mL, mean ± SEM) of control and BVDV inoculated ewes at GD 65 
and 80. Differences between gestational days (GD) denoted as # (P = 0.08) and * (P = 0.04). SEM, 





























Figure 5:  
Mean uterine vein PAG1 concentration (ng/mL) (mean ± SEM) of control and BVDV inoculated ewes at 

































Figure 6:  
Pearson’s correlation plots between uterine vein and jugular PAG1 concentrations between control 
(closed symbols) and BVDV (open symbols) groups at GD 80. A significant correlation was observed 





































Mean progesterone concentrations (ng/mL) (mean ± SEM) of ewes from all treatment groups 15 dpi.  
Mean progesterone concentrations for NON PREGNANT-BVDV group was significantly lower 
compared to PREGNANT-CTRL (P = 0.01, denoted as *). No significant difference was determined 































Figure 8:  
Evaluation of isolated exosomes and associated miRNA. (A) representative western blot showing the 
prescence of CD 81 and HSP 70, two characterized markers that define exosomes, isolated  from a sheep 
assigned to the PREGNANT – CTRL group along with positive (+) and negative (-) controls. (B) Agilent 
electropherogram profiles of small RNAs extracted from circulating exosomes. The base pair length [nt] 
(x axis) ploted against the fluorescence units [FU] (y axis). Note the clustering of RNA species below 60 







Figure 9:  







Figure 10:  






Representative western blot showing the presence of CD 81 and HSP 70, two characterized markers in 
serum derived exosomes from a sheep assigned to the PREGNANT – CTRL group along with positive 






Figure 12:  
Volcano Plot showing proteomic data between pregnant versus non-pregnant sheep (A) as well as control 
versus BVDV exposed sheep (B). The x-axis depicts large magnitude fold changes with statistical 
significance (-log10 of p value) depicted on the y-axis. The plot is colored such that the points have a fold 














Figure 13:  
















































Table 1:  
Most abundant circulating-exosome-derived miRNAs with differential abundance in sheep at 15 dpi. 
Mean abundance for each treatment group is displayed as log count per million reads.  Shading of counts 











bta-mir-10225b 1.719024 2.345936 1.719024 3.035236333 
bta-mir-11998 5.078831 4.268056 4.779501 3.382291333 
bta-mir-12022 8.028356 7.506199 7.784214 6.674143333 
bta-mir-1291 2.213358 2.650805 3.615292 5.544595667 
bta-mir-1388 3.969205 5.223099 5.747218 5.272334333 
bta-mir-144 6.702682 7.192592 8.381197 7.924628667 
bta-mir-187 1.866785 1.857453 3.304917 2.165693 
bta-mir-193a 1.719024 2.289512 3.375086 2.788254 
bta-mir-19a 2.829216 3.888565 4.998951 4.481507333 
bta-mir-2330 2.213358 1.719024 2.861422 1.719024 
bta-mir-2895 3.866853 3.124122 3.337584 2.255131667 
bta-mir-29c 1.719024 1.964811 1.719024 2.838988333 
bta-mir-34c 2.734612 2.942509 5.569437 3.891579 
bta-mir-449c 2.734612 2.066833 3.170745 2.056786667 
bta-mir-451 10.79098 11.29406 12.3562 11.95457633 
bta-mir-767 3.760724 4.237765 3.398481 3.158994667 
chi-mir-16a 3.693114 3.7939 5.393907 4.149750667 
chi-mir-2284c 4.160002 4.827474 3.810683 3.591750333 
chi-mir-29c 1.719024 1.857453 3.083628 2.056786667 
hsa-mir-4453 1.866785 1.719024 2.059024 2.395147333 
hsa-mir-4508 5.792865 4.48439 4.74379 4.442682 
hsa-mir-5193 3.280715 2.638698 3.228549 1.719024 
hsa-mir-6084 1.979656 1.719024 2.209571 2.724193 
hsa-mir-6128 2.053924 2.54147 1.719024 2.451586667 
hsa-mir-624 3.565997 1.914122 2.746937 1.991630333 
mmu-mir-5106 8.924946 7.892783 8.743697 7.599069 
mmu-mir-5119 7.6162 6.358208 7.318954 5.984148333 
mmu-mir-5124a 3.196456 2.461247 2.753091 1.719024 
mmu-mir-6368 2.510064 1.997888 3.885062 1.719024 
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mmu-mir-6990 3.230875 2.861578 1.984056 2.329991 
mmu-mir-719 3.351146 1.719024 3.129163 2.629221667 
oar-mir-194 3.19406 3.389861 5.459918 3.490387 
























Table 2:  
Select circulating-exosome-derived proteins with differential abundance in sheep at 15 dpi. Mean 
abundance is displayed as a ratio.  Shading of counts represents the quantity of reads (red = increased 
quantity, blue = decrease quantity). 
 











1.579 1.735 1.437 
Alpha-1-antiproteinase 1.633 1.874 1.423 
Alpha-2-HS-glycoprotein 0.283 0.333 0.241 
Antithrombin-III 0.701 0.744 0.66 
Apolipoprotein A-II 0.589 0.587 0.59 
Apolipoprotein C-III 0.621 0.666 0.578 
Complement factor H-
related protein 2 
0.653 0.655 0.651 
Complement factor H 0.556 0.649 0.476 
Fibrinogen alpha chain 0.639 0.628 0.651 
Fibrinogen beta chain 0.66 0.623 0.7 
Fibrinogen gamma chain 0.601 0.629 0.575 
Histidine-rich glycoprotein 0.711 0.821 0.615 
Immunoglobulin kappa-
2.1 light chain variable 
region 
1.419 1.288 1.564 
Immunoglobulin 
1.397 1.535 1.273 
light chain variable region 
Lumican 1.859 1.91 1.81 
Retinol-binding protein 4 0.586 0.605 0.567 
Serpin A3-5 2.181 2.711 1.755 




















2.007 1.721 2.34 
Zona pellucida sperm-
binding protein 3 receptor 
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